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Protected from host immune attack and antibiotic penetration by
their unique cell envelope, mycobacterial pathogens cause devas-
tating human diseases such as tuberculosis. Seamless coordination
of cell growth with cell envelope elongation at the pole maintains
this barrier. Unraveling this spatiotemporal regulation is a poten-
tial strategy for controlling mycobacterial infections. Our bio-
chemical analysis previously revealed two functionally distinct
membrane fractions in Mycobacterium smegmatis cell lysates:
plasma membrane tightly associated with the cell wall (PM-CW)
and a distinct fraction of pure membrane free of cell wall com-
ponents (PMf). To provide further insight into the functions of
these membrane fractions, we took the approach of comparative
proteomics and identified more than 300 proteins specifically
associated with the PMf, including essential enzymes involved
in cell envelope synthesis such as a mannosyltransferase, Ppm1,
and a galactosyltransferase, GlfT2. Furthermore, comparative
lipidomics revealed the distinct lipid composition of the PMf,
with specific association of key cell envelope biosynthetic pre-
cursors. Live-imaging fluorescence microscopy visualized the PMf
as patches of membrane spatially distinct from the PM-CW and
notably enriched in the pole of the growing cells. Taken to-
gether, our study provides the basis for assigning the PMf as a
spatiotemporally distinct and metabolically active membrane do-
main involved in cell envelope biogenesis.
mycobacteria | cell envelope | lipid biosynthesis | polar growth |
membrane domain
Tuberculosis, caused by the infection of Mycobacterium tuber-culosis (Mtb), is a disease that claims about 1.5 million human
lives annually (1). The thick, lipid-laden cell envelope of myco-
bacteria is composed of a plasma membrane, peptidoglycan-
arabinogalactan layer, and mycolate outer membrane that are
crucial for pathogenicity (2–4). The cross-sectional structure of
the five or more distinct layers that form static mycobacterial cell
envelope has been elucidated (2, 5). However, any mechanism
for lateral elongation of a multilayered structure has not been
defined. Most models posit that key components are synthesized
inside the plasma membrane, with subsequent transport to outer
layers of elongating cell wall (CW) (6). In mycobacteria, the
elongation of the cell envelope is restricted to the polar region of
the cell (7–10), suggesting the presence of spatiotemporal control
mechanisms to supply cell envelope biosynthetic intermediates to
this region (6). Indeed, a recent study demonstrated that key bio-
synthetic enzymes of the peptidoglycan-arabinogalactan-mycolic
acid core structure are specifically enriched in the subpolar region
of mycobacterial cells (11).
We previously reported membrane compartmentalization in
Mycobacterium smegmatis (Msmeg) (12). Density gradient frac-
tionation of mycobacterial lysate revealed a distinct fraction
containing plasma membrane free of the CW (PMf) in addition
to a fraction containing the classical plasma membrane tightly
associated with the CW (PM-CW). Both of these membranes are
composed of major phospholipids such as phosphatidyletha-
nolamine (PE), phosphatidylinositol (PI), and cardiolipin (12).
However, the PMf fraction is enriched in specific enzymes re-
lated to the biosynthesis of PE and PI mannosides (PIMs) (12),
implying its distinct role in phospholipid metabolism. To synthesize
phospholipids, mycobacteria use the cytidine diphosphate-
diacylglycerol (CDP-DAG) pathway (13), in which phosphatidic acid
(PA) is activated to CDP-DAG, and then converted to phospha-
tidylserine and PI (14). PE is produced from phosphatidylserine by
phosphatidylserine decarboxylase (Psd), and this enzyme activity is
enriched in the PMf (12). PIMs are made by sequential additions of
mannose onto a PI, and AcPIM2 and AcPIM6, containing two and
six mannose residues, respectively, are two major products. Al-
though these mature PIM species are distributed in both the PM-
CW and PMf, the enzymatic activities from PI to AcPIM2 and from
AcPIM2 to AcPIM6 are enriched in the PMf and the PM-CW,
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respectively (12). Furthermore, PimB′, the mannosyltransferase
that mediates the second mannose addition (15, 16), is specifically
associated with the PMf (17). In addition, polyprenol-phosphate-
mannose (PPM) is a lipidic mannose donor critical for the synthesis
of mannose-containing glycolipids such as AcPIM6, lipomannan,
and lipoarabinomannan. PPM synthase, composed of Ppm1 and
Ppm2, is essential for survival (18), and its activity is also enriched
in the PMf (12). Hence, biosynthetic reactions critical for cell en-
velope biosynthesis are associated with the PMf. However, whether
these enzymes are specifically bound to the PMf and whether the
PMf is a spatially distinct membrane in vivo remained un-
determined. In the current study, we combined large-scale analyt-
ical methods with live-cell imaging. Our data reveal the broader
composition of a spatiotemporally distinct membrane domain,
demonstrating colocalization of enzymes with the products of
lipid pathways in which they operate. These data support the
idea that the PMf is an organizing center for the biosynthesis of
specific metabolites in mycobacteria.
Results
The PMf Is a Multifunctional Membrane. To broadly understand the
protein composition of the PMf, we conducted a comparative
proteomic analysis and identified a total of 240 and 626 proteins
enriched in the PMf and the PM-CW, respectively (Dataset S1). We
used the DAVID gene functional classification tool (19) to reveal
enrichment of the transport and metabolic machineries of inorganic
ions, amino acids, and carbohydrates in the PM-CW (SI Appendix,
Fig. S1). The PM-CW was also enriched in enzymes involved in
protein trafficking, energy metabolism, and signal transduction (SI
Appendix, Table S1). Our proteomic analysis extends the key con-
clusion of our previous study that the PM-CW is the classical
plasma membrane tightly bound to the CW. In contrast, the PMf
was enriched in proteins involved in metabolism of specific cell
envelope components (SI Appendix, Fig. S1). As predicted, we ob-
served PimB′ (MSMEG_4253), Psd (MSMEG_0861), and Ppm1
(MSMEG_3859) in the pool of 240 PMf-enriched proteins, vali-
dating our analysis. Only eight of 240 PMf proteins were predicted
to have transmembrane (TM) domains (SI Appendix, Table S2)
(20), suggesting that most PMf-associated proteins are peripheral
membrane proteins.
Five of the newly identified PMf-associated proteins were chosen
for further analysis based on known or predicted function, abun-
dance, protein size, and the presence of a TM domain (SI Appendix,
Materials and Methods). They were GlfT2 (MSMEG_6403, UDP-
galactosyl transferase), Gtf1 (MSMEG_0389, glycosyltransferase), a
geranylgeranyl reductase (MSMEG_2308), PyrD (MSMEG_4198,
dihydroorotate dehydrogenase), and a putative membrane protein
(MSMEG_1944), of which the last two have predicted TM do-
mains. We expressed these proteins with a C-terminal HA tag in
wild-typeMsmeg (see SI Appendix, Fig. S15A for the vector design).
Western blotting of density gradient fractions showed that all the
selected proteins were enriched in the PMf fractions, colocalizing
with an endogenous PMf marker PimB′ (Fig. 1A and SI Appendix,
Fig. S2A).
Further analysis of GlfT2 and PyrD showed that both GlfT2-HA
and PyrD-HA coimmunoprecipitated with PimB′ from crude lysate
(Fig. 1B and SI Appendix, Fig. S2B). The coimmunoprecipitation
(IP) of PimB′ was dependent on the HA epitope tag (SI Appendix,
Fig. S2C). MptA (MSMEG_4241), a PM-CW mannosyltransferase
involved in the biosynthesis of lipomannan and lipoarabinomannan
(17), was not pulled down under the same conditions, and mild
detergents disrupted the co-IP of PimB′, consistent with the idea
that the PMf membrane mediates these protein interactions. Pre-
viously, negative-stain transmission electron microscopy (TEM)
revealed vesicle-like structures in the PMf fractions (12), termed
PMf vesicles. Immunogold TEM revealed both GlfT2-HA and
PimB′, detected by anti-HA and anti-PimB′ antibodies, respectively,
on the same PMf vesicles, reinforcing the co-IP results (Fig. 1C). Of
60 randomly chosen vesicles, 44 vesicles were detected by at least
one of the antibodies, and 10 vesicles were detected by both
(Fig. 1D). Control experiments established the specificity of this
detection (Fig. 1D and SI Appendix, Fig. S3 A–E). Taken to-
gether, these data indicate the PMf is a multifunctional mem-
brane bound by a specific set of proteins with known functions.
The Refined Proteome Indicates the Roles of the PMf in Lipid
Metabolism and Cell Envelope Biogenesis. Many PMf proteins
were categorized as having known functions in DNA replication and
protein translation, rather than membrane biogenesis (SI Appendix,
Fig. S1). In addition, GlnA1 (MSMEG_4290), an abundant gluta-
mine synthetase in mycobacteria (21) that forms a ∼600-kDa homo-
dodecamer (22), was highly enriched in the PMf (Dataset S1).
However, when GlnA1-HA was expressed, it did not colocalize with
nor coimmunoprecipitate PimB′ (SI Appendix, Fig. S2 A, D, and E).
Thus, large cytoplasmic protein complexes, such as GlnA1 and
those involved in DNA replication and protein translation,
contaminated the PMf fraction, likely as a result of overlapping
sedimentation properties.
We established an epitope tag-based purification system to
remove contaminants by creating a transgenic Msmeg strain with
the endogenous glfT2 gene replaced with an mCherry (mC) fusion
gene, HA-mC-glfT2 (SI Appendix, Fig. S15B). GlfT2 is an essential
galactosyltransferase for arabinogalactan biosynthesis (23–25).
Transgenic and wild-type strains grew at similar rates (SI Appen-
dix, Fig. S4A), suggesting that HA-mC-GlfT2 replaces the function
of the wild-type protein. After confirming the specific PMf local-
ization of HA-mC-GlfT2 (SI Appendix, Fig. S4B), we purified the
PMf by density gradient fractionation, followed by anti-HA IP,
and performed comparative proteomics on this and an identically
treated wild-type sample. Using a stringent criterion of 10-fold
enrichment in the PMf from HA-mC-GlfT2-expressing cells, we
detected 309 PMf-associated proteins (Dataset S1). Among them,
117 were present in the initial PMf proteome, including previously
Fig. 1. GlfT2-HA and PimB′ are bound to the same PMf membrane.
(A) Western blot of density gradient fractions of GlfT2-HA-expressing cell lysate.
GlfT2-HA, 74.9 kDa, anti (α)-HA; PimB′ (PMf marker), 41.4 kDa, α-PimB′; and
MptA (PM-CW marker), 54.3k Da, α-MptA. (B) Co-IP of GlfT2-HA and PimB′
and its disruption by mild detergent. Input is the equivalent amount of ly-
sate used in co-IP experiment. HES (Hepes at pH 7.4, EDTA, NaCl) and HESD
(HES with mild detergents) indicate buffers used for IP. (C) Negative-stain
immunogold TEM of the PMf from GlfT2-HA expressing cells illustrates
colocalization of GlfT2-HA (5 nm gold, open arrowheads) and PimB′ (10 nm
gold, solid arrowheads). (Scale bar, 100 nm.) (D) Quantification of immu-
nogold-labeled PMf vesicles treated with (as in C) or without (as a negative
control) primary antibodies. None, no gold particle detected on vesicle; Both,
at least one 5-nm and one 10-nm gold particle detected; HA, one or more
5-nm gold particles detected; and PimB′, one or more 10-nm gold particles
detected. n = 60.









characterized PimB′, PyrD, Ppm1, Gtf1, Psd, geranylgeranyl re-
ductase, and MSMEG_1944. Importantly, we no longer detected
GlnA1 or other suspected cytoplasmic contaminants. Instead, the
PMf was reaffirmed as a membrane enriched in proteins involved
in cell envelope biogenesis and lipid metabolism, as well as trans-
port and metabolism of secondary metabolites, amino acids, and
inorganic ions (SI Appendix, Fig. S4C). Notably, we found
acyltransferase MSMEG_2934 involved in AcPIM2 biosynthesis,
consistent with previous findings that the early steps of PIM
biosynthesis take place in the PMf (12). In addition, we found
putative DAG kinases (MSMEG_4335 and MSMEG_1920; the
orthologs of Mtb Rv2252 and Rv3218) (26) and 1-acylglycerol-3-
phosphate O-acyltransferase (MSMEG_4248; the ortholog of
Mtb Rv2182c) (27, 28) enriched in the PMf. These enzymes
function in two independent pathways of PA biosynthesis, in-
dicating the possibility that the PMf is the site of PA production,
a hypothesis investigated in detail later. Collectively, proteomic
analysis indicated the PMf as a specialized membrane–protein
complex with defined and interrelated metabolic functions.
Comparative Lipidomics Supports Specialized Biosynthetic Function
of the PMf. Selective association of lipid biosynthetic enzymes
with the PMf suggested that the lipid composition of the PMf and
PM-CW might be different. Using an established normal phase
HPLC-mass spectrometry (MS) platform and mycobacteria-spe-
cific ion databases (29, 30), we completed comparative lipidomics
analysis of the PMf and PM-CW. Biological quadruplicate anal-
yses detected 11,079 molecular events, which represent linked
m/z, retention time, and intensity values (Fig. 2A). After aligning
datasets as paired events with equivalent mass and retention time
values and calculating ion intensity ratios for all pairs, we enu-
merated the molecular events that changed in intensity above a
high threshold value (twofold, Benjamini-Hochberg corrected P <
0.05). We found 642 and 796 events that were significantly over-
represented in the PMf and PM-CW, respectively (Fig. 2A and
Datasets S2 and S3). Thus, 13% of all lipids met this stringent
change criterion, demonstrating broad differences in lipid com-
position of the two fractions.
Identification of Altered Lipids. The m/z and retention time values
embedded in changed events could be used to identify the bio-
chemical identities of key lipids corresponding to the changed
events. Because the large number of changed events (1,438)
precluded identification of all lipids by collision-induced disso-
ciation MS (CID-MS), we used recently validated methods to
prioritize events for biochemical analysis (31, 32). These criteria
included detection of multiple isotopes of the same molecular
ion (M) or mass intervals characteristic of alkane series with
more than one member detected. We further focused on the
abundant mycobacterial membrane phospholipids in the Myco-
Mass and MycoMap databases (29), using their reported m/z and
retention time values for preliminary identifications of matching
Fig. 2. Lipidomic profiling of the PMf and PM-CW by MS reveals shared and distinct lipids. (A) Volcano plot of ions detected after HPLC-MS. Individual ions
(circles) detected in the positive and negative ion modes were combined and plotted based on fold-change and statistical significance in PM-CW versus PMf,
using paired samples (n = 4). The horizontal dashed line indicates P < 0.05 (Benjamini-Hochberg corrected P value); the vertical dashed lines indicate twofold
change. The intensity of individual points indicates their relative ion intensity. All lipids indicated by arrows in A were subjected to CID-MS to identify ions of
interest, with five representative lipids shown in B–F. PE (35:0) and PI were detected in both fractions (B and C). Monoacyl PI trimannoside (AcPIM3) was
PM-CW-enriched (D). TAG (52:1) and PA (34:2) were PMf-enriched (E and F). The chemical structures and fragments detected after tandem MS are shown.
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ions (Fig. 2A). Tentative identifications obtained by database
matching were validated using CID-MS analysis for at least one
member of each class (Fig. 2 B–F; SI Appendix, Figs. S5–S9 and
Table S3, indicated by CID-MS Y; SI Appendix, Table S4). Other
members of the indicated class were assigned when nearly
identical retention times and mass variations typical of acyl chain
length or unsaturation were detected (SI Appendix, Table S3,
indicated by CID-MS N).
Major phospholipid species such as PI (35:0; i.e., 35 carbon
chain with no unsaturated bond) and PEs (32:2, 34:1, 34:2, and
35:0) (33) were equally distributed between the PM-CW and the
PMf (Fig. 2 A and B and SI Appendix, Fig. S5 and Tables S3 and
S4), consistent with previous TLC analysis (12). Consistent with
the previous observations that the biosynthetic steps after AcPIM2
take place in the PM-CW (12), AcPIM3 species were enriched
in the PM-CW fraction (Fig. 2 A and D and SI Appendix, Fig. S7
and Table S3). We also found three acyl forms of Ac2PIM2
enriched in the PM-CW, suggesting that inositol acylation to
produce tetra-acyl PIMs may take place in the PM-CW as well. In
contrast, the PMf is enriched in lipid species that are likely in-
volved in core glycerolipid metabolism. Notably, we found four PA
species (32:1, 34:0, 34:1, 34:2) enriched in the PMf (Fig. 2 A and F
and SI Appendix, Fig. S9 and Tables S3 and S4). This correlates
with the enrichment of PA-producing enzymes in the PMf pro-
teome, as described earlier. Similarly, TAGs (51:1, 52:1) were
enriched in the PMf (Fig. 2 A and E), and we found a putative
TAG synthetase (Tgs) (MSMEG_0290) enriched in the PMf
(Dataset S1). In contrast, DAG, the substrate for Tgs, was
found in both the PMf and the PM-CW, although only one acyl
species (34:1) could be reliably detected (Discussion). Taken
together, despite having a similar major phospholipid com-
position to the PM-CW, the PMf is uniquely enriched in spe-
cific lipid species that correspond to the enzymatic content of
the fraction.
The PMf Exists as Discrete Patches in LiveMsmeg Cells. In addition to
the HA-mC-GlfT2 strain described earlier, we created a second
strain to visualize the PMf by live-imaging fluorescence micro-
copy. In this strain, endogenous Ppm1 was replaced with the
fusion protein Ppm1-mNeonGreen (mNG)-cMyc (SI Appendix,
Fig. S15B). Ppm1 is the essential catalytic subunit of PPM syn-
thase (18) and was identified in the refined PMf proteome
(Dataset S1). The transgenic strain grew at a rate comparable to
wild type, implying that the fusion protein is functional (SI Ap-
pendix, Fig. S10A). Furthermore, the fusion protein localized to
the PMf during density gradient fractionation (SI Appendix, Fig.
S10B). We visualized the PMf using these strains expressing ei-
ther HA-mC-GlfT2 or Ppm1-mNG-cMyc, and showed that the
PMf formed foci of variable size and intensity throughout the
cells, with particularly intense foci at the poles (Fig. 3A). To
determine whether the fluorescent patches were artificial ag-
gregates induced by fusion proteins (34), we expressed GlfT2
fused with a monomeric mTurquoise2 (mT) in the HA-mC-
GlfT2-expressing strain (35). We confirmed PMf localization by
density gradient fractionation (SI Appendix, Fig. S11A) and
showed that fluorescent patterns of mT-GlfT2-FLAG paralleled
HA-mC-GlfT2 patterns (SI Appendix, Fig. S11B). Previously
reported autofluorescence from wild-type Msmeg (36) was neg-
ligible compared with the fluorescence from mT-GlfT2-FLAG
expressed in wild-type cells (SI Appendix, Fig. S12). These data
rule out common artifacts that sometimes occur with protein
engineering within bacterial cells and corroborate a method for
tracking key PMf markers.
To compare the fluorescent patterns of the PMf and PM-CW,
we introduced a PimE-GFP-FLAG expression vector in the
HA-mC-GlfT2-expressing strain. PimE is a PM-CW-associated
enzyme involved in AcPIM6 biosynthesis (37), although it was
not identified in the PM-CW proteome, likely because it is a
highly hydrophobic membrane protein (Dataset S1). We confirmed
that PimE-GFP-FLAG was enriched in the PM-CW-containing
fraction of density gradients (SI Appendix, Fig. S11C). In strik-
ing contrast to HA-mC-GlfT2 fluorescence, PimE-GFP-FLAG
revealed annular fluorescent patterns, in addition to apparent
septal fluorescence, consistent with the PM-CW as the classical
plasma membrane tightly associated with CW (Fig. 3B).
To examine the colocalization of the two PMf proteins,
HA-mC-GlfT2 and Ppm1-mNG-cMyc, we generated another
transgenic strain in which both endogenous GlfT2 and Ppm1 were
replaced with HA-mC-GlfT2 and Ppm1-mNG-cMyc, respectively.
This transgenic strain grew at a similar rate to wild type, implying
functional proteins (SI Appendix, Fig. S10A). We confirmed PMf
localization of both proteins by density gradient fractionation (SI
Appendix, Fig. S10 C and D). We then showed overlapping in vivo
localization of these two proteins (Fig. 3C), with the Pearson
colocalization coefficient of 0.89 ± 0.06 (n = 20), which was sub-
stantially higher than the coefficient of 0.37 ± 0.16 (n = 20) for
HA-mC-GlfT2 (PMf) and PimE-GFP-FLAG (PM-CW) shown
in Fig. 3B. Thus, the PMf is spatially distinct from the plasma
membrane in live Msmeg cells.
Enrichment of the PMf Is Spatiotemporally Correlated to Actively
Growing Poles. Mycobacteria grow from their polar ends, where
we found the strongest enrichment of HA-mC-GlfT2 and Ppm1-
mNG-cMyc foci (Fig. 3). Time-lapse microscopy of the strain
expressing both PimE-GFP-FLAG and HA-mC-GlfT2 showed
that PimE-GFP-FLAG stably associated with the plasma mem-
brane, whereas HA-mC-GlfT2 foci continuously associated with
the growing poles (Fig. 4A and Movie S1). In an alternative
approach, we stained the preexisting CW with a fluorescent
amine-reactive dye, washed the dye, allowed the cells to grow,
and visualized the growth of the unlabeled poles (9). We found
that the unlabeled growing poles possessed HA-mC-GlfT2 foci
Fig. 3. Live imaging of the PMf markers in Msmeg, showing discrete
patches of the PMf. (A) HA-mC-GlfT2 (Left) and Ppm1-mNG-cMyc (Right)
expressing cells showing punctate PMf foci often enriched at the poles of the
cells. (B) Coexpression of PimE-GFP-FLAG (PM-CW) and HA-mC-GlfT2 (PMf)
demonstrates distinct fluorescent patterns. (C) Two PMf-associated proteins
(HA-mC-GlfT2 and Ppm1-mNG-cMyc) colocalize in single cells. In all panels,
arrowheads indicate polar foci. (Scale bar, 5 μm.) Two representative cells are
shown in each panel.









(SI Appendix, Fig. S13). These data indicated that the PMf-
associated proteins are enriched in the growth pole of the cell.
To further test the temporal correlation of the PMf with polar
cell envelope elongation, we induced ectopic polar growth and
abnormal branching of the HA-mC-GlfT2-expressing cells by
transiently treating the cells with D-cycloserine (DCS). We found a
fraction of cells initiating growth at ectopic poles during the re-
covery from DCS-induced growth arrest (Movie S2). Importantly,
HA-mC-GlfT2 was observed at the site of bifurcation during
branching initiation (Fig. 4B) and continuously enriched at the
ectopic, DCS-induced growth pole. Thus, our data indicate PMf
localization to the poles of mycobacterial cells in two models
of growth.
Discussion
Organized lipid microdomains in live mycobacteria were reported
in 1999 (38), using fluorescent lipid probes. More recently, car-
diolipin enrichment was observed at the septa and poles of actively
growing cells with the fluorescent dye 10-N-nonyl acridine orange
(39). These studies suggested that the mycobacterial membrane is
not entirely homogenous. However, the physiological significance
of these observations remained unclear.
In this study, we presented three independent lines of evidence
supporting the existence of functionally specialized membrane
domain in mycobacteria. First, proteomic analysis identified more
than 300 putative proteins that specifically associate with the PMf.
Identification of PimB′, Psd, and Ppm1 verified our previous ob-
servations (12). In addition, PimB′, and Ppm1 are essential en-
zymes (16, 18), indicating the critical role of the PMf as a site of
essential lipid biosynthetic reactions. We confirmed the PMf as-
sociation of six proteins by density gradient fractionation and
performed further analyses on GlfT2, Ppm1, and PyrD. GlfT2
does not contain predicted TM domains, but rather, its crystal
structure implies peripheral membrane association (40). Extend-
ing previous studies showing that GlfT2 cofractionates with both
membrane and CW (24), our data demonstrated stable and spe-
cific binding of GlfT2 to the PMf membrane. In contrast, the
membrane association of Ppm1 is mediated by the formation of a
heterodimer with the membrane protein Ppm2 (41), which may
dictate PMf localization. We did not detect Ppm2 in our PMf
proteome, likely because of the highly hydrophobic nature of
Ppm2. The PMf association of GlfT2 and Ppm1 predicts that the
galactan precursor and PPM, the products of these enzymes, may
be found in the PMf lipidome. However, they are transient bio-
synthetic intermediates and could not be identified by our current
analysis. PyrD is a family 2 quinone-dependent dihydroorotate
dehydrogenase (42) involved in pyrimidine biosynthesis. It is
predicted to be essential in Mtb (43) and is hypothesized to in-
teract with the PMf membrane through a predicted TM domain.
Whereas precise molecular mechanisms of how these different
proteins associate with the PMf membrane remain to be de-
termined, our data indicate that the PMf harbors multiple es-
sential biosynthetic enzymes.
Second, we established that the PMf has a distinct lipid compo-
sition from that of the classical plasma membrane. We confirmed
our previous observation that PE and PI, major phospholipid spe-
cies, are equally distributed in both membrane fractions, suggesting
that the PMf and the classical plasma membrane are formed by
certain ubiquitous phospholipids. In contrast, all four detectable
acyl forms of PA are enriched in the PMf, reinforcing the in-
terpretation of the PMf as a metabolically active membrane with
specialized function (SI Appendix, Fig. S14). In addition to the PA-
producing enzymes, the PMf proteome was enriched in a putative
glycerol phosphate acyltransferase (MSMEG_4703) (Dataset S1)
that mediates the committed step of PA biosynthesis, further sug-
gesting that glycerolipid biosynthesis initiates in the PMf (SI Ap-
pendix, Fig. S14). Interestingly, a DAG species was present in both
membrane fractions, suggesting the subsequent reaction of TAG
synthesis can take place in either membrane. Among eight Msmeg
homologs of Mtb Tgs enzymes (44), we found MSMEG_0290
enriched in the PMf, consistent with the enrichment of TAG species
in the PMf. However, two other Tgs homologs, MSMEG_5242 and
MSMEG_1882, were found in the PM-CW, suggesting that TAGs
can be made in both membranes but does not accumulate in the
PM-CW. Thus, our data may offer a spatially dynamic perspective
on the TAG metabolism in mycobacteria (SI Appendix, Fig. S14).
Regarding the PIM biosynthesis, we could not identify intermedi-
ates such as PIM1 and PIM2 in the lipidome, likely because of their
low abundance. Nevertheless, we identified AcPIM2 biosynthetic
proteins such as acyltransferase MSMEG_2934 and PimB′ in the
PMf proteome (SI Appendix, Fig. S14), confirming the previous
studies suggesting that AcPIM2 is produced in the PMf (12). The
absence of the first mannosyltransferase PimA in the PMf proteome
was expected because it is an amphipathic enzyme transiently as-
sociating with membrane by weak ionic interactions (12, 45). Be-
cause AcPIM2 is found in both membranes, AcPIM2 produced in
the PMf must be distributed to the PM-CW. Although further
studies are needed to characterize dynamic features of individual
metabolic pathways, our current study clearly demonstrates the
distinct lipid composition of the PMf with correlative association of
specific enzymes.
Fig. 4. The spatiotemporal correlation of the PMf and polar CW elongation.
(A) Frame shots of time-lapse microscopy (Movie S1) of the PimE-GFP-FLAG/
HA-mC-GlfT2 dual-expressing cells illustrate the stable annular fluorescence
of the PM-CW and the continuous association of the PMf foci at the growing
cell poles. Time (minutes) represents the real time since the start of the re-
cording. (Scale bar, 10 μm.) (B) Two representative time-lapse movies of HA-
mC-GlfT2-expressing Msmeg cells during the recovery phase after transient
exposure to DCS (see Movie S2 for sample 1) show the correlation of newly
created ectopic polar growth and the PMf foci. The time indicates when the
frame shots were taken in relation to the first frame in real time. Arrows,
branch point; arrowheads, polar ectopic growth. (Scale bar, 15 μm.)
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Finally, we showed that the PMf forms spatially distinct patches
with particular enrichment at the poles of live cells. We further
showed temporal correlation of PMf markers with the growth of
cell poles. Taken together, the current study provided evidence for
the PMf as a spatiotemporally distinct membrane domain in which
specific biosynthetic reactions take place. Although enriched at
the pole, two observations suggest the PMf is not simply a purified
cell pole. First, fluorescent patterns of the PMf membrane domain
indicate it distributes throughout the cell as discrete patches in
addition to polar enrichment. We speculate that these less intense
nonpolar patches are involved in cell envelope maintenance,
rather than elongation. Second, some pole-associated proteins are
not enriched in the PMf. Most notably, DivIVA, a well-known
pole-associated protein (11, 46), was enriched in the PM-CW,
rather than the PMf (Dataset S1). Taken together, we conclude
that the PMf is a membrane domain spatially distinct not only
from classical plasma membrane but also from some known polar
structures. We suggest that the PMf acts as an organizing center
for multiple biosynthetic enzymes that are critical for cell envelope
biogenesis in mycobacteria.
Materials and Methods
Plasmids were made using standard molecular biology techniques (SI Ap-
pendix, Fig. S15). Growth of mycobacterial strains, preparation of lysates,
and fractionation of lysates by sucrose density gradient were as described
(12), with modifications in SI Appendix. Full descriptions of other methods
are given in SI Appendix.
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Movie S1. Time-lapse microscopy of the HA-mCherry-GlfT2/PimE-GFP-FLAG dual-expression strain grown on an agar pad at 37 °C. Images were recorded for
18 h at 15-min intervals. The movie was recorded at 1,800× real-time speed.
Movie S1
Movie S2. Time-lapse microscopy of the HA-mCherry-GlfT2-expressing strain after DCS treatment. Representative time-lapse experiment in a constant-feed
custommicrofluidic device. The cells were grown in a supplemented Middlebrook 7H9 medium (Materials and Methods) at 30 °C. DCS at 40 μg/mL was added at
10 h and removed at 16 h. Images were recorded at 15-min intervals after removal of DCS. The movie was recorded at 5 frames per second.
Movie S2
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Figure S1. The protein populations of the PM-CW and the PMf are different. The PM-CW is 
enriched in proteins involved in transport and metabolisms of carbohydrates, amino acids, and 
inorganic ions. The PM-CW also has a population of proteins involved in signal transduction, cell 
envelope biogenesis, and posttranslational modification. The PMf is enriched in lipid metabolism 
and cell envelope biogenesis. DNA replication and protein translational machinery are also 
enriched in the PMf, but these proteins are contaminants (see Fig. S4C).  
 
Figure S2. Biochemical verification of PMf-associated proteins identified by proteomic 
analysis. (A) Association of HA-tagged proteins to the PMf. Lysates of Msmeg cells expressing 
HA-tagged proteins were fractionated by sucrose density gradient, and HA-tagged proteins were 
detected by western blotting. Protein bands were quantified to calculate % distribution. (B) PyrD-
HA (38.2 kDa), an HA-tagged PMf-associated protein co-immunoprecipitates with endogenous 
PimB’, a known PMf protein. MptA is a marker for the PM-CW. (C) Anti-HA agarose beads co-
immunoprecipitate neither PimB’ nor MptA from a wild-type cell lysate, showing that co-IP is 
dependent on the HA-tagged proteins.  (D) GlnA1-HA (54.6 kDa), a non-PMf protein, does not 
localize to the PMf. The PMf fractions are identified by the localization of PimB’ (41.4 kDa) and the 
PM-CW fractions are identified by the localization of MptA (54.3 kDa). (E) GlnA1-HA pulls down 
neither PimB’ nor MptA. 
 
Figure S3. Immunogold labeling of Msmeg PMf fractions. (A) Immunogold labeling of the PMf-
containing density gradient fraction of GlfT2-HA expressing cells without primary antibodies. The 
samples were labeled with colloidal gold-conjugated secondary antibodies only, and quantified as 
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in Fig. 1D. (B) Immunogold labeling of the PMf-containing density gradient fraction of wild-type 
(WT) cells without primary antibodies, but with colloidal gold-conjugated secondary antibodies 
only. (C) Immunogold labeling of the PMf-containing density gradient fraction of wild-type cells 
with anti-PimB’ primary antibody and colloidal gold-conjugated secondary antibody. (D) 
Immunogold labeling of the PMf-containing density gradient fraction of wild-type cells with anti-
HA primary antibody and colloidal gold-conjugated secondary antibody. Bar = 100 nm. Closed 
arrowheads = 10 nm gold, anti-PimB’ antibody. (E) Quantification of the wild-type colloidal gold 
antibody staining from Figure S3B-D. None, no gold particle detected on vesicle; HA, one or more 
5 nm gold particles detected; and PimB’, at least one 10 nm gold particles detected. N=60. 
 
Figure S4. Replacement of the endogenous GlfT2 with HA-mCherry-GlfT2 for an improved 
PMf proteome. (A) Growth curves of HA-mCherry-GlfT2 (orange) expressing cells in comparison 
to wild type (green) demonstrates growth is not inhibited by the gene replacement. Growth of 
each strain was measured in triplicate and standard deviations are shown. (B) HA-mCherry-GlfT2 
(99.6 kDa) localizes to the PMf by density gradient fractionation. The PMf, identified by PimB’ 
(41.4 kDa); and the PM-CW, identified by MptA (54.3 kDa). (C) Protein function categorization of 
the refined PMf proteome generated from highly purified PMf sample by the DAVID gene 
functional classification tool demonstrates enrichment of biosynthetic processes including cell 
envelope and lipid biogenesis. 
 
Figure S5. Ion at m/z 732.568 identified as phosphatidylethanolamine. CID spectrum of 
precursor ion 732.568 labeled with measured m/z values and error in parts per million (ppm) for 
matches to deduced fragments that match known values within 10 ppm. The maximum centroid 
peak intensity of a single scan is shown. The dashed red line indicates the parent ion. Dotted blue 
lines indicate the masses of expected fragments based on the deduced chemical structure. Inset 
shows the chemical structure of PE. 
 
Figure S6. Ion at m/z 851.57 identified as phosphatidylinositol. CID spectrum of precursor ion 
851.57 labeled with measured m/z values and error in parts per million (ppm) for matches to 
deduced fragments that match known values within 10 ppm. The maximum centroid peak 
intensity of a single scan is shown. The dashed red line indicates the parent ion. Dotted blue lines 
indicate the masses of expected fragments based on the deduced chemical structure. Inset shows 
the chemical structure of PI. Isomers likely exist but cannot be differentially detected by this 
method. 
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Figure S7. Ion at m/z 1575.95 identified as AcPIM3. CID spectrum of precursor ion 1575.95 
labeled with measured m/z values and error in parts per million (ppm) for matches to deduced 
fragments that match known values within 10 ppm. The maximum centroid peak intensity of a 
single scan is shown. The dashed red line indicates the parent ion. Dotted blue lines indicate the 
masses of expected fragments based on the deduced chemical structure. Inset shows the 
chemical structure of AcPIM3. Deduced fragment masses in the inset formatted with italics were 
not detected at < 10 ppm but are intermediates for fragments that were detected. Isomers likely 
exist but were not resolved. 
 
Figure S8. Ion at m/z 878.82 identified as triacylglycerol. CID spectrum of precursor ion 
878.82 labeled with measured m/z values and error in parts per million (ppm) for matches to 
deduced fragments within 10 ppm. The maximum centroid peak intensity of a single scan is 
shown. The dashed red line indicates the parent ion. Dotted blue lines indicate the masses of 
expected fragments based on the deduced chemical structure. Inset shows the chemical structure 
of TAG. Isomers likely exist but were not resolved. 
 
Figure S9. Ion at m/z 671.466 identified as phosphatidic acid. CID spectrum of precursor ion 
671.466 labeled with measured m/z values and error in parts per million (ppm) for matches to 
deduced fragments that match known values within 10 ppm. The maximum centroid peak 
intensity of a single scan is shown. The dashed red line indicates the parent ion. Dotted blue lines 
indicate the masses of expected fragments based on the deduced chemical structure. Inset shows 
the chemical structure of PA. 
 
Figure S10. Ppm1 is a PMf protein and colocalizes with GlfT2 in vitro. (A) Ppm1-mNG-cMyc-
expressing cell lines grow similarly to wild-type Msmeg. Blue diamond, wild type; red square, 
Ppm1-mNG-cMyc expressing cells; green triangle, HA-mCherry-GlfT2 and Ppm1-mNG-cMyc dual 
expressing cells. Growth of each strain was measured in triplicate and standard deviations are 
shown. (B) Ppm1-mNG-cMyc (59.1 kDa) protein localized to the PMf containing fractions by 
sucrose gradient. The PMf, identified by PimB’ (41.4 kDa); and the PM-CW, identified by MptA 
(54.3 kDa). (C) Distribution of two PMf markers (HA-mCherry-GlfT2, 99.6 kDa, and Ppm1-mNG-
cMyc, 59.1 kDa) in a single cell line by sucrose gradient demonstrates fusion protein localization 
biochemically to the PMf-containing fractions. The PMf fractions are identified by the localization 
of PimB’ (41.4 kDa) and the PM-CW fractions are identified by the localization of MptA (54.3 kDa). 
(D) Immunoprecipitation of HA-mCherry-GlfT2 from dual expressing (HA-mCherry-GlfT2, 99.6 
kDa, and Ppm1-mNG-cMyc, 59.1 kDa ) cell lysate pulls down the other PMf proteins, endogenous 
PimB’ (41.4 kDa) and Ppm1-mNG-cMyc (59.1 kDa), but not the PM-CW marker MptA (54.3 kDa).  
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Figure S11. Fluorescent fusion proteins show the localization of the PMf and the PM-CW. (A) 
Biochemical analysis of the fluorescent protein localizations show that both the mTurquoise- and 
mCherry-labeled GlfT2 proteins (mTurQ-GlfT2-FLAG, 101.6 kDa; and HA-mCherry-GlfT2, 99.6 
kDa) localize to the PMf-containing fractions. The PMf, identified by PimB’ (41.4 kDa); and the 
PM-CW, identified by MptA (54.3 kDa). (B) Fluorescent fusion proteins of GlfT2 (mTurQ-GlfT2-
FLAG and HA-mCherry-GlfT2) colocalize. (C) Distribution of a PMf-associated fusion protein (HA-
mCherry-GlfT2, 99.6 kDa) and a PM-CW associated fusion protein (PimE-GFP-FLAG, 82.3 kDa) 
along a sucrose gradient demonstrates their different in vitro localizations. The PMf, identified by 
PimB’ (41.4 kDa); and the PM-CW, identified by MptA (54.3 kDa). 
 
Figure S12. Autofluorescence does not account for the blue fluorescence from mTurquoise-
GlfT2-FLAG expressing cells. All fluorescent images were captured by 3 s exposures, and 
processed identically. Note that blue auto-fluorescence in wild-type cells is negligible. 
 
Figure S13. The spatiotemporal correlation of the PMf and polar CW elongation examined by 
chemical labeling of CW. (A) New cell envelope growth, represented by the absence of AlexaFluor 
488 amine-reactive dye (white bars), correlates with the HA-mC-GlfT2 foci (arrowheads). 
Bar=5μm. (B) Quantitation of AlexaFluor 488 staining and HA-mC-GlfT2 foci along the cell 
length. Cell images were sliced into 10 sections and average fluorescent intensities of 5 slices 
from the center to the pole were quantified in arbitrary fluorescent units (a.u.). n=214 cells. 
 
Figure S14. Working model for the compartmentalization of glycerolipid biosynthesis 
pathways in M. smegmatis revealed by proteome and lipidome analyses. The data obtained 
from the proteome and lipidome were compiled to demonstrate one possible correlative 
interpretation of how the enzymes and lipids can interact with membrane compartments in 
mycobacteria. MSMEG_ accession numbers are indicated for known or putative enzymes involved 
in the pathway. Subcellular localization of proteins and lipids are color-coded as indicated. 
AcPIM6/lipomannan (LM)/lipoarabinomannan (LAM) biosynthesis pathways are abbreviated 
beyond AcPIM3 because we identified neither the enzymes nor the lipid intermediates. PI and PE 
are major phospholipid products. Another major phospholipid species, cardiolipin, was omitted 
because we did not find any enzymes involved in the cardiolipin biosynthesis. AcPIM2 and 
Ac2PIM2 are well-established products of the PIM biosynthesis pathway. Ac2PIM1 is a minor 
product, which is not well-characterized. G3P, glycerol-3-phosphate; PA, phosphatidic acid; DAG, 
diacylglycerol; TAG, triacylglycerol; FA-CoA, fatty acyl-CoA; CDP-DAG, cytidine diphosphate DAG; 
PPi, pyrophosphate; PI, phosphatidylinositol; PE, phosphatidylethanolamine; PS, 
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phosphatidylserine. GPAT, glycerol phosphate acyltransferase; AGPAT, acylglycerol phosphate 
acyltransferase; PAP, PA phosphatase; DAGK, DAG kinases; TGS, TAG synthetase; Psd, PS 
decarboxylase; PimA, PimB’ and ManT, mannosyltransferases; Man AcylT, mannose 
acyltransferase; and Ino AcylT, inositol acyltransferase.  
 
Figure S15. Plasmid maps of those used in this study. (A) Expression vectors used in this study. 
(B) The genomic structure of glfT2 and ppm1 after markerless gene replacement.  
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Table S1. Proteins identified in a manual scan as part of energy metabolism, lipoproteins, 
protein trafficking, and signal transduction in the PM-CW. 
 





















0028	   serine/threonine-­‐protein	  kinase	  pknB	  
0110	   NAD(P)	  transhydrogenase	  subunit	  alpha	  	   0030	   serine/threonine-­‐protein	  kinases	  pknA	  	  
0690	   iron-­‐sulfur-­‐binding	  reductase	  	   0033	   serine/threonine	  phosphatase	  PPP	  
0847	   NADH-­‐ubiquinone	  oxidoreductase	  chain	  4L	  	   0246	   sensor-­‐type	  histidine	  kinase	  prrB	  	  
1654	   Isocitrate	  dehydrogenase	  (NADP)	  Icd2	  	   0786	   serine/threonine-­‐protein	  kinase	  pknG	  	  
1669	  
succinate	  dehydrogenase	  iron-­‐sulfur	  
protein	  subunit	  SdhB	  	   0963	   sensor-­‐like	  histidine	  kinase	  senX3	  	  
1670	  
succinate	  dehydrogenase	  flavoprotein	  
subunit	  	   1874	   two-­‐component	  response	  regulator	  	  
2351	   Electron	  transfer	  flavoprotein	  beta	  subunit	  	   1875	   sensor	  histidine	  kinase	  mtrB	  
2352	   electron	  transfer	  flavoprotein	  subunit	  alpha	  	   2087	   mechanosensitive	  ion	  channel	  protein	  MscS	  
2613	   Malate:quinone	  oxidoreductase	  Mqo	   3677	   serine/threonine-­‐protein	  kinase	  pknF	  	  
3233	   cytochrome	  ubiquinol	  oxidase	  subunit	   4243	   serine/threonine-­‐protein	  kinase	  pknL	  	  
3710	   cytochrome	  B561	   4366	   serine/threonine-­‐protein	  kinase	  pknD	  
4260	   cytochrome	  c	  oxidase	  subunit	  3	  	   4989	   Two-­‐component	  sensor	  kinase	  TcrY	  	  
4261	   Ubiquinol-­‐cytochrome	  C	  reductase	  QcrC	   5487	   Two-­‐component	  sensor	  kinase	  MprB	  
4263	   Ubiquinol-­‐cytochrome	  C	  reductase	  QcrB	  	   5663	   sensor-­‐type	  histidine	  kinase	  prrB	  	  
4268	  
transmembrane	  cytochrome	  C	  oxidase	  
(Subunit	  II)	  ctaC	  	   5870	   sensor	  protein	  	  
4437	   cytochrome	  c	  oxidase	  subunit	  1	   6130	   two-­‐component	  system	  sensor	  kinase	  
4936	   ATP	  synthase	  subunit	  beta	   6880	   extracellular	  ligand-­‐binding	  receptor	  	  











2424	   signal	  recognition	  particle-­‐docking	  FtsY	  	  
4939	   ATP	  synthase	  subunit	  H	  	   2960	   protein	  translocase	  subunit	  yajC	  
4940	   ATP	  synthase	  subunit	  F	  	   2961	   protein-­‐export	  membrane	  protein	  secD	  







0138	   MCE-­‐family	  lipoprotein	  LprK	   3174	   lipoprotein	  signal	  peptidase	  
0787	   glutamine-­‐binding	  lipoprotein	  GlnH	  	   3247	   extracellular	  ligand-­‐binding	  receptor	  	  
0929	   lipoprotein	  lprQ	  	   3654	   protein	  translocase	  subunit	  secA	  
1039	  
FEIII-­‐dicitrate-­‐binding	  periplasmic	  
lipoprotein	  FecB	  	   3886	   sec-­‐independent	  protein	  secretion	  pathway	  component	  TatC	  
1876	   lipoprotein	  lpqB	  	   4183	   preprotein	  translocase	  subunit	  secY	  	  
2369	   lipoprotein	  lppZ	  	   5872	   Two	  component	  system	  response	  transcriptional	  positive	  regulator	  phoP	  
2439	   alanine	  rich	  lipoprotein	  lppW	  	  
2441	   Signal	  peptidase	  I	  LepB	  	  
3851	   protein	  LppI	  
4196	   lipoprotein	  lppL	  	  
4239	   protein	  LppM	  
4475	   protein	  LppP	  	  
5005	   lipoprotein	  LprC	  	  
5007	   lipoprotein	  lprB	  
5017	   lipoprotein	  	  
5061	   sugar-­‐binding	  lipoprotein	  LpqY	  
5416	   lipoprotein	  LpqU	  	  
5429	   lipoprotein	  lpqT	  
5513	   LpqN	  
6109	   lipoprotein	  lpqG	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Table S2. PMf-associated proteins with predicted TM domains.  
 
Accession	  #	   MSMEG_	   	   #	  of	  TM	  
gi|399984455	   0023	   Hypothetical	  protein	  MSMEI_0025	   1	  
gi|399985957	   1576	   Alpha/beta	  hydrolase	  fold	  protein	   1	  
gi|399986320	   1944	   Membrane	  protein	   2	  
gi|399988056	   3738	   GTP-­‐binding	  protein	  engA	   1	  
gi|399988200	   3887	   Sec-­‐independent	  protein	  translocase	  tatA/E	   1	  
gi|399988503	   4290	   Dihydroorotate	  dehydrogenase	   1	  
gi|399988821	   4535	   Glycoside	  hydrolase	  15-­‐related	  protein	   2	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Table S3. Summary statistics of representative lipids. The identity of at least one compound in 
each family was established through repeat experiments using collision-induced dissociation 
mass spectrometry (CID-MS, Y).  Other members of the indicated family were assigned when ions 
showing nearly identical retention times and mass variations typical of alkyl change length or 
unsaturation were detected (CID-MS, N). 
	  
Lipid	  Class	   Subclass	   Formula	   xcms	  Name	  
m/z	  
Deviation	  





PMf	  up	  (+)	  







intensity	  Expected	   Observed	  
glycerides	  
diacylated	  
C36H70O5	   M601T179p	   600.557	   600.553	   -­‐6.1	   [M+NH4]+	   N	   -­‐0.79	   0.3209	   16.62	  
C37H70O5	   M613T185p	   612.557	   612.557	   0.35	   [M+NH4]+	   Y	   -­‐0.08	   0.9095	   23.03	  
C37H72O5	   M615T183p	   614.572	   614.565	   -­‐12	   [M+NH4]+	   N	   -­‐1.06	   0.4905	   19.25	  
C38H74O5	   M629T183p	   628.588	   628.585	   -­‐5.4	   [M+NH4]+	   N	   -­‐1.87	   0.0403	   19.53	  
C39H74O5	   M641T614p	   640.588	   640.588	   -­‐0.67	   [M+NH4]+	   N	   0.19	   0.8232	   19.47	  
triacylated	  
C53H100O6	   M851T183p	   850.786	   850.784	   -­‐2.21	   [M+NH4]+	   Y	   1.67	   0.0589	   20.9	  
C54H102O6	   M865T184_1p	   864.802	   864.792	   -­‐11.66	   [M+NH4]+	   N	   1.4	   0.12	   17.73	  
C55H104O6	   M879T185p	   878.818	   878.815	   -­‐2.86	   [M+NH4]+	   Y	   1.96	   0.0291	   20.84	  
C57H108O6	   M907T184p	   906.849	   906.847	   -­‐2.53	   [M+NH4]+	   Y	   1.92	   0.0862	   19.84	  
C59H112O6	   M935T188p	   934.88	   934.876	   -­‐4.84	   [M+NH4]+	   N	   0.48	   0.7307	   17.82	  
C60H116O6	   M951T157p	   950.911	   950.903	   -­‐8.95	   [M+NH4]+	   N	   0.91	   0.4081	   14.81	  
C61H116O6	   M963T185p	   962.912	   962.909	   -­‐2.18	   [M+NH4]+	   N	   1.68	   0.0624	   20.98	  
C62H120O6	   M979T158p	   978.943	   978.933	   -­‐10.06	   [M+NH4]+	   N	   1.09	   0.4436	   15.68	  
C63H122O6	   M993T152p	   992.958	   992.95	   -­‐8.12	   [M+NH4]+	   N	   1.24	   0.371	   15.04	  
phosphatidic	  acids	  
	   	  
C35H67O8P	   M645T457n	   645.45	   645.45	   0.37	   [M-­‐H]-­‐	   Y	   1.89	   0.0056	   19.28	  
C37H69O8P	   M671T454n	   671.466	   671.466	   -­‐0.14	   [M-­‐H]-­‐	   Y	   1.75	   0.0218	   20.1	  
C37H71O8P	   M673T428n	   673.481	   673.481	   -­‐0.34	   [M-­‐H]-­‐	   Y	   1.49	   0.014	   20.97	  
C37H73O8P	   M675T419n	   675.497	   675.491	   -­‐8.86	   [M-­‐H]-­‐	   Y	   2	   0.0118	   18.04	  
phosphatidyl-­‐
ethanolamine	  
	   	  
C35H70O8NP	   M662T1171n	   662.477	   662.477	   0.6	   [M-­‐H]-­‐	   N	   0.21	   0.8148	   18.83	  
C37H70O8NP	   M686T1174n	   686.477	   686.476	   -­‐0.81	   [M-­‐H]-­‐	   Y	   -­‐0.05	   0.9382	   18.44	  
C37H72O8NP	   M688T1164n	   688.492	   688.493	   0.4	   [M-­‐H]-­‐	   N	   -­‐0.2	   0.6797	   21.76	  
C37H74O8NP	   M691T1167n	   690.508	   690.506	   -­‐2.22	   [M-­‐H]-­‐	   N	   -­‐0.75	   0.2578	   20.42	  
C39H74O8NP	   M715T1159n	   714.508	   714.508	   0.26	   [M-­‐H]-­‐	   Y	   -­‐0.07	   0.9009	   22.1	  
C39H76O8NP	   M717T1192n	   716.524	   716.524	   0.53	   [M-­‐H]-­‐	   Y	   -­‐0.03	   0.9696	   24.17	  
C39H78O8NP	   M719T1170n	   718.539	   718.531	   -­‐12.03	   [M-­‐H]-­‐	   N	   -­‐0.51	   0.3742	   20.95	  
C40H78O8NP	   M731T1234n	   730.539	   730.537	   -­‐2.43	   [M-­‐H]-­‐	   N	   0.7	   0.1868	   18.94	  
C40H80O8NP	   M733T1200n	   732.555	   732.554	   -­‐1.82	   [M-­‐H]-­‐	   Y	   -­‐0.53	   0.5083	   21.42	  
phosphatidylinositol	  
	   	  
C41H79O13P	   M810T1541n	   809.519	   809.511	   -­‐9.73	   [M-­‐H]-­‐	   N	   0.23	   0.6617	   18.79	  
C42H81O13P	   M824T1514n	   823.534	   823.538	   4.22	   [M-­‐H]-­‐	   N	   0.28	   0.5351	   20.44	  
C43H79O13P	   M834T1533n	   833.519	   833.522	   4.3	   [M-­‐H]-­‐	   N	   0.52	   0.2625	   22.28	  
C43H81O13P	   M836T1515n	   835.534	   835.539	   5.2	   [M-­‐H]-­‐	   N	   0.17	   0.7265	   25.83	  
C43H83O13P	   M838T1514n	   837.55	   837.543	   -­‐8.62	   [M-­‐H]-­‐	   N	   0.26	   0.5546	   22.9	  
C44H83O13P	   M850T1500n	   849.55	   849.553	   4.13	   [M-­‐H]-­‐	   N	   0.63	   0.1681	   22.05	  
C44H85O13P	   M852T1484n	   851.566	   851.569	   4.67	   [M-­‐H]-­‐	   Y	   0.22	   0.5938	   24.99	  
C45H85O13P	   M864T1484n	   863.566	   863.566	   0.13	   [M-­‐H]-­‐	   N	   0.12	   0.7979	   20.39	  
C45H87O13P	   M866T1482n	   865.581	   865.576	   -­‐6.23	   [M-­‐H]-­‐	   N	   0.64	   0.2327	   18.39	  
C46H87O13P	   M878T1477n	   877.581	   877.581	   0.02	   [M-­‐H]-­‐	   N	   0.97	   0.103	   17.38	  
C46H89O13P	   M880T1463n	   879.597	   879.597	   0.33	   [M-­‐H]-­‐	   N	   0.51	   0.3363	   18.7	  
phosphatidylinositol	  






C72H135O24P	   M1414T1720n	   1413.901	   1413.901	   -­‐0.08	   [M-­‐H]-­‐	   N	   -­‐0.84	   0.2176	   23.1	  
C74H139O24P	   M1442T1696n	   1441.932	   1441.931	   -­‐0.57	   [M-­‐H]-­‐	   N	   -­‐0.32	   0.6053	   17.75	  
diacyl	  
	  
C88H165O25P	   M1671T1501p	   1671.172	   1671.164	   -­‐4.52	   [M+NH4]+	   Y	   -­‐1.2	   0.0436	   19.01	  
C90H169O25P	   M1680T1470n	   1680.162	   1680.156	   -­‐3.13	   [M-­‐H]-­‐	   N	   -­‐0.78	   0.1386	   18.38	  
C91H171O25P	   M1713T1469p	   1713.219	   1713.21	   -­‐4.88	   [M+NH4]+	   Y	   -­‐2.32	   0.0367	   16.86	  
phosphatidylinositol	  
trimannoside	   monoacyl	   C78H145O29P	   M1576T1991n	   1575.954	   1575.946	   -­‐4.77	   [M-­‐H]-­‐	   Y	   -­‐1.86	   0.0068	   18.96	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Table S4.  CID fragmentation of alkyl series. Parent and CID fragments detected by mass 
spectrometry for ions in addition to those profiled in Figure 2 & Figures S5-S9. 
 












(ppm)	   Intensity	  Expected	   Observed	  
glycerides	  
diacylated	   C37H70O5	   612.557	   25	   175.44	  
C19H37O3+	   313.274	   313.273	   1.18	   5136.29	  
C21H39O3+	   339.289	   339.289	   0.37	   2917.70	  
C21H41O3+	   341.305	   341.304	   3.56	   54.13	  
C37H69O4+	   577.519	   577.517	   3.63	   1277.17	  
triacylated	  
C53H100O6	   850.786	   25	   193.38	  
C35H65O4+	   549.488	   549.485	   5.09	   96.90	  
C35H67O4+	   551.503	   551.502	   2.40	   463.09	  
C54H102O6	   864.802	   25	   169.5	  
C36H69O4+	   565.519	   565.516	   4.96	   175.78	  
C38H71O4+	   591.535	   591.535	   0.11	   114.78	  
C38H73O4+	   593.550	   593.550	   1.15	   27.08	  
C57H108O6	   906.849	   25	   172.5	  
C37H69O4+	   577.519	   577.521	   3.97	   325.69	  
C39H73O4+	   605.550	   605.546	   7.04	   103.01	  
C39H75O4+	   607.566	   607.570	   6.74	   580.44	  
C41H77O4+	   633.582	   633.577	   7.63	   273.00	  
phosphatidic	  acids	  
	   	  
C35H67O8P	   645.45	   25	   428.76	  
C3H6O5P-­‐	   152.996	   152.996	   2.52	   896.99	  
C14H27O2-­‐	   227.202	   227.203	   5.62	   480.09	  
C16H29O2-­‐	   253.217	   253.217	   0.00	   132.08	  
C18H33O2-­‐	   281.249	   281.250	   5.56	   1377.39	  
C37H71O8P	   673.481	   35	   433.92	  
C3H6O5P-­‐	   152.996	   152.996	   1.57	   664.12	  
C16H29O2-­‐	   253.217	   253.220	   8.97	   98.01	  
C16H31O2-­‐	   255.233	   255.233	   0.99	   1170.56	  
C18H33O2-­‐	   281.249	   281.249	   0.41	   3156.61	  
C37H73O8P	   675.497	   25	   509.22	  
C3H6O5P-­‐	   152.996	   152.995	   3.36	   97.90	  
C16H31O2-­‐	   255.233	   255.233	   1.59	   115.41	  
C18H33O2-­‐	   281.249	   281.249	   2.69	   56.01	  





C37H70NO8P	   686.488	   35	   1287.48	  
C5H11NO5P-­‐	   196.038	   196.036	   8.55	   134.08	  
C14H27O2-­‐	   227.202	   227.207	   21.40	   25.50	  
C16H29O2-­‐	   253.217	   253.220	   12.08	   147.56	  
C18H33O2-­‐	   281.249	   281.252	   10.22	   156.95	  
C39H74NO8P	   714.515	   45	   1452.66	  
C5H11NO5P-­‐	   196.038	   196.041	   13.89	   15.44	  
C16H29O2-­‐	   253.217	   253.221	   12.74	   173.01	  
C39H76NO8P	   716.538	   35	   1965.54	  
C5H11NO5P-­‐	   196.038	   196.040	   10.60	   72.07	  
C16H29O2-­‐	   253.217	   253.215	   10.34	   11.01	  
C16H31O2-­‐	   255.233	   255.235	   9.75	   608.89	  
C18H33O2-­‐	   281.249	   281.247	   4.78	   289.00	  
C19H37O2-­‐	   297.280	   297.285	   15.33	   48.08	  
phosphatidylinositol	  
monomannosides	   diacyl	   C82H155O20P	   1492.092	   45	   1455.9	  
C38H73O4+	   593.550	   593.550	   1.40	   46.60	  




diacyl	   C88H165O25P	   1671.172	   45	   1438.14	  
C35H67O4+	   551.503	   551.507	   6.53	   10.03	  
C38H73O4+	   593.550	   593.549	   1.92	   2222.64	  
C88H169NO25P+	   1671.172	   1671.176	   2.39	   14.67	  
diacyl	   C91H171O25P	   1713.219	   45	   1646.34	  
C38H73O4+	   593.550	   593.556	   9.47	   53.53	  
C91H175NO25P+	   1713.219	   1713.228	   5.55	   6.00	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Plasmid	   Gene	  ID	   Protein	   Forward	  Primer	  Reverse	  Primer 
pYAB279	   MSMEG_0389	   Gtf1	   ATTAAATTTGTGCTGGCGAGTTACG ATTCGCCGAACACCTCGACCT 
pYAB280	   MSMEG_2308	   Geranylgeranyl	  reductase	  
ATTCTGACCTGCTCAGACCGC 
ATTCTTCTTGATGACGTGCTGCG 
pYAB281	   MSMEG_6403	   GlfT2	   ATTAGTGACATCCCTTCCGGC ATTTCGTCCGACTTTCTCCGGT 
pMUM012	   MSMEG_4290	   GlnA1	   ATTGATATCGTGGCAGAAAAGACGTCCGA ATTAGTACTCACGTCGTAGTAGAGCGAGAACT 
pMUM015	   MSMEG_4290	   GlnA1	   GTGGCAGAAAAGACGTCCGA CACGTCGTAGTAGAGCGAGAACT 
pMUM023	   MSMEG_4198	   PyrD	   ATCCATATGTACCGCGTTCTGCGG ACTGCGCACGGCTGATCCGACA 
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Dataset Legends 
 
Dataset S1. List of proteins associated with PMf, PM-CW, or refined PMf identified by 
proteomic analysis. This dataset is provided as a separate Excel separate file. First tab, PM-CW; 
second tab, PMf; and third tab, refined PMf.  
 
Dataset S2. The quadruplicate analysis of the PMf and PM-CW lipidomes. This dataset is 
provided as a separate Excel file. 
 
Dataset S3. R script for the lipidomics analysis. A script in .R format for all aspects of the 
lipidomics analysis including ion peak picking and statistical analysis. Dataset S2, Figure 2 and 
Figures S5-9 were produced using this script. Raw MS data are available by request. 
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Materials and Methods 
 
Construction of plasmids 
Main features of each plasmid are summarized in Fig. S15.  
pYAB186 — To create an expression vector for PimE-GFP-FLAG (pYAB186), pYAB052 (1) was 
digested with SspI, and pEGFP-C1 (Clontech Laboratories) was digested with EcoRI and AgeI. The 
EGFP fragment was then blunt ended and ligated into the pYAB052 fragment.  
pYAB279, pYAB280, pYAB281, and pMUM015 — To create expression vectors for 
MSMEG_0389 (pYAB279), MSMEG_2308 (pYAB280), MSMEG_6403 (pYAB281), and GlnA1 
(pMUM015), genes were amplified by PCR (Table S5), and the PCR products were then inserted by 
blunt-end ligation to pYAB178 after removing pimB’ gene by SspI. pYAB178 is a hygromycin-
resistant integrative PimB’-HA expression vector (not used in this study), which is based on 
pMV361 (2). It was designed so that pimB’ gene can be excised from pYAB178 in frame by SspI, a 
blunt-end 6-bp cutter. The digested fragment can then be used to insert other genes by blunt-
end ligation to create an expression vector for C-terminally HA epitope-tagged fusion proteins.  
pMUM012 — pMUM012 was used only to clone genes encoding PyrD and MSMEG_1944 
(pMUM023 and pMUM024, see below). To create, pMUM011, a streptomycin-resistant derivative 
of pYAB178 (see above), was digested with SspI to remove the pimB’ gene, and the PCR product 
5’-SspI-EcoRV-glnA1-ScaI-SspI-3’ (restriction enzyme sites underlined in Table S5) was inserted 
by blunt-end ligation.  
pMUM023 and pMUM024 — The genes encoding PyrD (pMUM023) and MSMEG_1944 
(pMUM024) were amplified by PCR (Table S5). pMUM012 was digested with EcoRV and ScaI to 
remove an inserted gene in frame, and the PCR fragments carrying pyrD and msmeg_1944 genes 
were inserted by blunt-end ligation, creating expression vectors for C-terminally HA epitope-
tagged fusion proteins.  
pMUM043 — To construct the mTurquoise-GlfT2-FLAG expression vector, the mTurquoise 
gene was amplified from an Escherichia coli strain carrying mTurquoise using the primers (Table 
S5). The PCR product was digested with MfeI and inserted into the MfeI site of pYAB281. We then 
amplified the 3’ region of GlfT2 from pYAB281 using the primers (Table S5) to add the FLAG tag 
in frame with the GlfT2 coding region. This PCR fragment as well as mTurquoise-inserted 
pYAB281 were digested with ClaI and PmlI and ligated together to create pMUM043. 
pMUM053 — To replace the endogenous glfT2 gene with a gene encoding HA-mCherry-
GlfT2, we amplified upstream and downstream regions of glfT2 using the primers shown in Table 
S5, and digested with AlwNI and DraIII, respectively. We also amplified mCherry using the primers 
shown in Table S5, and digested with DraIII. HA epitope was synthesized with appropriate sticky 
ends (Table S5). All 4 fragments were ligated into pCOM1 (Tiwari S and Jacobs WR Jr., 
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unpublished) at Van91I sites. The resulting plasmid, pMUM053, was transformed into Msmeg by 
electroporation, and positive clones were isolated using hygromycin resistance marker and SacB-
dependent sucrose sensitivity. Correct replacement of the glfT2 gene was confirmed by PCR.  
pMUM072 — To replace the endogenous ppm1 gene with a gene encoding Ppm1-
mNeonGreen-cMyc, we amplified upstream and downstream regions of ppm1 using the primers 
shown in Table S5, and digested with AlwNI. Both fragments and Van91I-digested pCOM1 
fragment were ligated, resulting in pMUM070. VspI and BspTI sites introduced to the primers to 
amplify the upstream and downstream regions of ppm1 (underlined in Table S5) were used to 
linearize pMUM070. We then amplified mNeonGreen-cMyc with VspI and BspTI at 5’ and 3’ ends, 
respectively (Table S5), digested with VspI and BspTI, and ligated into the pMUM070 fragment. 
The resultant plasmid pMUM072 was transformed into Msmeg by electroporation, and positive 
clones were selected as described for pMUM053 (see above). 
 
Cell culture and transformation 
M. smegmatis mc2155 was grown at 30°C in Middlebrook 7H9 broth supplemented with 11 mM 
glucose, 14.5mM NaCl, and 0.05% Tween-80, or at 37°C on Middlebrook 7H10 agar 
supplemented with 11 mM glucose and 14.5mM NaCl, unless otherwise indicated. Plasmid 
constructs (SI Appendix, Fig. S15) were electroporated into Msmeg cells as before (3). Antibiotic 
concentrations used were 100μg/ml hygromycin (Wako) and 50μg/ml streptomycin (Fisher 
Scientific).  
 
Density gradient fractionation 
Log phase cells (OD600 = 0.5-1.0) were pelleted, washed in 50 mM Hepes (pH 7.4) buffer and 
resuspended in lysis buffer (25 mM Hepes, pH 7.4, 20% Sucrose, 2 mM EGTA, and a protease 
inhibitor cocktail) at 1 g wet pellet to 5 ml lysis buffer. Cell suspension was then subjected to 
nitrogen cavitation at ~2250 psi for 30min three times. Lysate was spun at 3220x g for 10 min at 
4°C twice before loaded on a 20-50% sucrose gradient. Gradients were spun at 218,000x g for 6 
h at 4°C, fractionated into 1 ml fractions, and used for further biochemical analysis.  
 
Proteome preparation and analysis 
PMf and PM-CW proteomics samples were prepared by pelleting pooled sucrose density gradient 
fractions (PMf: 4-6, PM-CW: 8-10) at 100,000x g and washed with HES buffer (25mM HEPES 
pH7.4, 2mM EGTA, 150mM NaCl). Protein samples were separated on SDS-PAGE (12% gel) for a 
short distance and a gel slice containing entire unresolved protein band was digested with trypsin 
or chymotrypsin. The extracted peptide fragments were then analyzed by data-dependent nano-
LC ESI MS on an Orbitrap mass spectrometer (Thermo Scientific Q Exactive).  
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The data were batch searched against the Msmeg proteome database, using the Mascot 
search engine (Matrix Science, London, UK; version 2.4.0). We searched the Msmegmatis_81012 
database (6690 entries) with a parent ion mass tolerance of 10.0 ppm and a fragment ion mass 
tolerance of 0.050 Da. Carbamidomethyl of cysteine was specified as a fixed modification. Pyro 
glutamic for N-terminal glutamine, oxidation of methionine and acetyl of the protein N-terminus 
were specified as variable modifications. Scaffold (version 4.3.2, Proteome Software Inc., Portland, 
OR) was then used to validate MS/MS based peptide and protein identifications. Peptide 
identifications were accepted if they could be established at greater than 92.0% probability by the 
Peptide Prophet algorithm (4). Protein identifications were accepted if they could be established at 
greater than 90.0% probability and contained at least 2 identified peptides. Protein probabilities 
were assigned by the Protein Prophet algorithm (5). Proteins that contained similar peptides and 
could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles 
of parsimony. To calculate relative protein abundances, the exponentially modified protein 
abundance index (emPAI) was used in the Scaffold program (6). Identified proteins with minimum 
spectral counts of 10 and a twofold or greater enrichment in either the PMf or the PM-CW were 
deemed to be part of the respective proteome.  
Protein identification numbers were input into the UniProt Retrieve/ID Mapping function, the 
UniProt Identification numbers retrieved, and subsequently subjected to DAVID Bioinformatics 
Functional Annotation tool to be classified into GO Ontology groups. To select the PMf-associated 
proteins for further biochemical analysis, we used several independent criteria such as known or 
predicted function in cell envelope biogenesis, their abundance (MS spectral counts, >20), protein 
size (<50 kDa), and the presence of a TM domain. GlfT2 (MSMEG_6403, UDP-galactosyl 
transferase) was chosen for the abundance (spectral counts of 149 from trypsin digests) and 
known function; Gtf1 (MSMEG_0389, glycosyltransferase) and a geranylgeranyl reductase 
(MSMEG_2308) are chosen for their predicted function, abundance (spectral counts of 21 and 183 
from trypsin digests), and a relatively small size (46.5 and 43.1 kDa respectively); PyrD is a 
quinone-dependent dehydrogenase and was chosen for abundance (spectral counts of 50 from 
trypsin digests), a relatively small size  (37.2 kDa), and the presence of predicted TM domain; and 
MSMEG_1944 was chosen despite the fact that it has no known functions because it is a unique 
protein in having a particularly small size (13.9 kDa) with two predicted TM domains.  
 
SDS-PAGE and western blotting 
Protein samples were mixed with a reducing sample loading buffer, denatured on ice, and run in a 
12% SDS-PAGE gel. Proteins were transferred to a PVDF membrane (BioRad), blocked in 5% milk in 
PBST20 (PBS with 0.05% Tween 20). Membranes were incubated with primary antibodies (anti-HA 
(Sigma), anti-PimB’ (7), and anti-MptA (7)) at 1:2000 dilutions, washed in PBST20, and incubated 
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with horseradish peroxidase-conjugated secondary antibodies (Sigma) at 1:2000 dilutions. Blots 
were washed again in PBST20 and developed for chemiluminescence. Images were recorded using 
an ImageQuant LAS 4000mini (GE Healthcare). For western blotting of sucrose gradients, an equal 
volume of each fraction was loaded into the gel. All experiments were repeated at least twice. The 
tagged protein in each fraction was quantified from western blot images by ImageJ. The amount 
of tagged protein detected in the major gradient categories (Cytoplasm, Fr. 1-2; PMf, Fr.4-6; PM-
CW, Fr. 9-11) was summed and a percentage of detected tagged protein was calculated by 
category. 
 
Immunoprecipitation of PMf proteins in membrane fractions  
Cell lysate (3.6 mg wet pellet equivalent in 18 µl) was diluted 1:20 in HES or HESD (HES plus 1% 
Triton X-100 and 1% sodium deoxycholate) buffer, and mixed with 2.5% total volume of anti-HA 
agarose beads (Sigma) pre-equilibrated with either HES or HESD. After overnight incubation at 
4°C, beads were washed with the respective buffers, and bound proteins were eluted by 1 mg/ml 
HA peptides (AnaSpec Inc) at 30°C for 15 min, twice. SDS-PAGE and western blotting were 
performed as before (7). All experiments were repeated at least twice to confirm the 
reproducibility.  
 
Negative staining EM 
Formvar-coated grids (Ted Pella) were incubated with sample (the PMf fraction from various 
strains as indicated in the Figure Legends) for 5 min, washed with dilution buffer (PBS with 2% 
BSA), incubated with primary antibody (anti-HA and/or anti-PimB’) for 30-60 min, washed in 
buffer, and incubated with colloidal gold-conjugated secondary antibody (Ted Pella) for 30 min. 
Finally, grids were washed in buffer, then water, and stained with 2% uranyl acetate for 2 min. 
Grids were desiccated for 3-5 d. Samples on the grids were observed at 15-25,000x using a JOEL 
JEM-2000FX Transmission Electron Microscope with a LaB6 electron source. A vesicle was defined 
as an oval shape having a minimum short axis of 38 nm and a maximum long axis of 85 nm. 
Most structures were circular with an average diameter of 55 nm. Sixty vesicles from each grid 
were quantified for their antibody binding. All experiments were repeated at least twice to confirm 
the reproducibility. 
 
Refined PMf proteome preparation and analysis 
The PMf fractions from cells expressing HA-mCherry-GlfT2 or from wild type cells were pooled 
and applied to a 10-µl bed volume of washed anti-HA agarose beads (Sigma) on a rotating wheel 
overnight at 4˚C as described above. Samples were then run in a 12% acrylamide gel for a short 
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distance, entire unresolved protein band cut out, digested with trypsin, and analyzed by LC-ESI 
MS as described previously.  
The proteome data were analyzed as above except that the Scaffold (version 4.4.5) was used 
and peptide identification threshold was set at 80.0% probability. To calculate relative protein 
abundances, the intensity-based absolute quantification (iBAQ) was used in the Scaffold program. 
Identified proteins with minimum quantitative iBAQ value of 2.0x107 and a 10-fold or greater 
enrichment in the transgenic PMf sample over that of wild type were deemed to be part of the PMf 
proteome. The protein identification numbers were submitted to UniProt Retrieval/ID Mapping, 
and the list of retrieved UniProt numbers was subjected to the DAVID Bioinformatics software 
Functional Annotation program as above. 
 
HPLC-MS lipidomic analysis 
Sucrose density gradient fractions containing either PMf or PM-CW were generated from wild-type 
lysate, and subjected to chloroform/methanol/water (8:4:3) partition. The lower organic phase 
was washed twice with chloroform/methanol/water (3:48:47). Ten percent of the volume was 
removed for quantification by orcinol staining of TLC plates using Fiji (8), and the final organic 
phase was dried under nitrogen. This was repeated for four independent samples, with the PMf 
and PM-CW fraction for each sample treated as a pair. 
The dried samples were resolvated at a concentration of 1 mg lipid per milliliter in 
hexanes/isopropanol (7:3) with 0.1% (v/v) formic acid and 0.05% (v/v) ammonium hydroxide for 
lipidomic profiling. Samples were centrifuged at 2,000 rpm for 10 min prior to transfer to 
autosampler vials (Agilent). HPLC separation and MS were performed as described (9) using an 
Agilent Technologies 6530 Accurate-Mass Q-TOF with a monochrome diol column. Twenty μl 
volumes of samples were injected in randomized order. Each set of injections was repeated in 
randomized blocks in positive and negative ion mode two times, with additional injections 
performed using CID-scanning mode. Additional CID-MS data were collected with the same 
samples at energies between 25-65 V. 
Raw profile mode data were converted to centroid mode and mzData format using 
MassHunter (Agilent). Ion peaks were identified, grouped and aligned using the R package XCMS 
(10) treating positive and negative mode data separately. Zero values were replaced using random 
minima and samples were normalized by full quantiles. Technical replicates were averaged and 
positive and negative ion mode data joined for statistical analysis. The R package limma (11) was 
used to identify ions meeting criteria for differential expression between the PMf and PM-CW, 
treating the PMf and PM-CW fractions for each of the four samples as a pair. Ions with an adjusted 
p value <0.05 (12) and a fold-change >2 were considered significantly different. A complete R 
script for analysis including all XCMS and limma parameters is available as supplemental 
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information (Datasets S2-S3). Ions were identified by matching mass and retention time to the 
MycoMap and MycoMass databases (9) followed by CID-MS. 
 
Fluorescent microscopy 
Msmeg cells expressing fluorescent proteins were grown in Middlebrook 7H9 media to 
logarithmic phase (OD600 = 0.5-1.0), 2 µl of cells were spotted onto a 1% agar pad made from 
Middlebrook 7H9 medium, and covered with a glass coverslip. All static live cell images were 
taken under identical settings (100x objective and 175 ms exposure for phase contrast or 3 s 
exposure for fluorescence), using a Nikon ECLIPSE E600 microscope equipped with ORCA-ER 
cooled CCD camera (Hamamatsu) and Openlab software 5.5.2 (Improvision). Pearson co-




Standard time-lapse imaging was performed as before (13). Briefly, bacteria were grown on an 
agar pad and images were taken every 15 min for a duration of 18 h using a DeltaVision Personal 
DV microscope equipped with an environmental chamber warmed at 37°C (Applied Precision). 
 
Cell wall labeling  
Msmeg cells were grown to logarithmic phase (OD600 = 0.5-1.0), pelleted, washed with PBS, 
labeled with amine-reactive Alexa Fluor 488 succinimidyl esters (Invitrogen) at a final 
concentration of 0.05 mg/ml, pelleted, washed with PBS and replaced into fresh media. Cells were 
allowed to grow for 2.5 h at 30°C, shaking, and imaged as above. Newly elongated CW was 
differentiated from preexisting CW by chemical staining as before (14) and intensity profiles of 
fluorescent probes were analyzed by contouring randomly selected 214 cells using 
MicrobeTracker (15), and quantifying using MATLAB R2012a (Mathworks). Statistical significance 
was determined by Student’s t-test.  
 
Induction of ectopic growth poles  
For DCS treatment, cells were grown to logarithmic phase and then loaded into a custom-built 
constant-feed microfluidic device (14) for live cell imaging. A DeltaVision PersonalDV widefield 
fluorescence microscope with solid state illumination and hardware-based autofocus was used to 
image cells every 15 min in a controlled environmental chamber warmed to 30°C. Growth medium 
(Middlebrook 7H9 supplemented with 0.05% Tween-80 and 10% ADC) was passed through the 
microfluidic device for 10 h before treatment for 6 h with 40 µg/ml of DCS. Antibiotic treatment 
was followed by an 8 h recovery in regular medium. 
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# Analysis of PMf vs PM-CW at MS1 and MS2 for Yasu Morita
#
# This is an R script containing all of the parameters and statistical
# analysis for the lipidomics experiments.
# Running the script will produce Figure 2A, Figures S5-9, Table S3 and
# Dataset S2.
#
# To repeat the analysis using this script:
# 1) Request the mass spec data files, or start with XCMS diffreport
# files provided
# which contain the peaks picked by XCMS using the parameters found
# found in xcmsFun to run the MS1 analysis
#
# 2) Download the MycoMap and MycoMass databases, available at:
# http://www.brighamandwomens.org/research/depts/medicine/rheumatology/
Labs/Moody/default.aspx
# The Excel files must be renamed/reformated to R-friendly files.
# or use the provided, curated files
#
# 3) The tandem MS data are provided as a RDS file.
# Raw data are available on request
#
# 4) Set file paths that make sense for your computer.



















# function to perform xcms peak picking, grouping, etc
# input a file path and xcms setting
# output an xcmsSet object (default)
# or diffreport object (if diffreport=TRUE)
# the object must be assigned or it will just print
# The diffreport can be saved instead of made into an object
# with save.table=TRUE and filebase=some_name
# saved reports can be read with:
# pl.xcms <- read.table("~//filebase.tsv")
# The diffreport MUST have levels to compare, set by level.1 and level.2
xcmsFun <- 
function(path=".", method='centWave', ppm=10, snthresh=5, 
peakwidth=c(20,120), prefilter=c(1,100), noise=0, integrate=1, 
fitgauss=FALSE, verbose.columns=TRUE, bw=30, minfrac=0.5, mzwid=0.25, 
level.1=1, level.2=2, diffreport=FALSE, save.table=FALSE, filebase=NULL
)
{
mzdatafiles <- list.files(path, recursive=TRUE, full.names=TRUE)
xset <- xcmsSet(mzdatafiles, method=method, ppm=ppm, snthresh=snthresh, 
peakwidth=peakwidth, prefilter=prefilter, noise=noise, integrate=integrate, 
fitgauss=fitgauss, verbose.columns=verbose.columns)
xset
xset <- group(xset, bw=bw, minfrac=minfrac, mzwid=mzwid)
xset
xset2 <- retcor(xset, family="s", plottype="m")
xset2 <- group(xset2, bw=bw, minfrac=minfrac, mzwid=mzwid)




















xm <- apply(x,2, function(z)
{
    m <- min(z[z!=0])
    z[z==0]<-runif(sum(z==0),0,m)
    z
    })
m <- apply(x,2, function(z) min(z[z!=0]))
if(output == "min") {
list(xm=xm,m=m)
}





# Default fullQuantileNorm works well
runNorm <-
function(x, method = "fullQuantileNorm")
{
if(method == "fullQuantileNorm") {
# Full Quantile
fullQuantileNorm <- function(x, y=rep(1,ncol(x)))
  {
    x.fq <- x
    for(i in unique(y))
      x.fq[,y==i] <- normalizeQuantile(x[,y==i], robust=TRUE)




else if(method == "globalScalingNorm") {
#Global
globalScalingNorm <- function(x, y=rep(1,ncol(x)), f = function(z) 
quantile(z, probs=0.75))
  {
    n <- apply(x, 2, f)
    for(i in unique(y))
      n[y==i] <- n[y==i] - f(x[,y==i])




else if(method == "pc1Norm") {
# PC1
pc1Norm <- function(x, y=rep(1,ncol(x)))
  {
    x.pc1 <- x
    for(i in unique(y))
      {
        s <- svd(x[,y==i])
        u <- s$u[,1]
        x.pc1[,y==i] <- apply(x[,y==i], 2, function(z) (z - 
sum(z*u)*u/sum(u^2)))
      }

















m <- lapply(1:num.peaks, matches)
met.index <- lapply(1:num.peaks, function(i) m[[i]][,1])
num.matches <- sapply(m, nrow)
metabolite <- sapply(1:num.peaks, function(i) if(num.matches[i]>=1) 
paste(db[(met.index[[i]][1:length(met.index[[i]])]), dbnames], collapse="; 
") else paste("ND"))
class <- sapply(1:num.peaks, function(i) if(num.matches[i]>=1) 
paste(unique(db[(met.index[[i]][1:length(met.index[[i]])]), dbclass]), 
collapse="; ") else paste(""))
}
data.frame(cbind(x, num.matches, metabolite, class))
}
dbMatch_2 <-
function(x, mzmedcol, db, dbnames, dbclass, dbcol, mass_tolerance=0.012, 













m <- lapply(1:num.peaks, matches)
met.index <- lapply(1:num.peaks, function(i) m[[i]][,1])
















m <- lapply(1:num.peaks, matches)
met.index <- lapply(1:num.peaks, function(i) m[[i]][,1])
num.matches <- sapply(m, nrow)
}
metabolite <- sapply(1:num.peaks, function(i) if(num.matches[i]>=1) 
paste(db[(met.index[[i]][1:length(met.index[[i]])]), dbnames], collapse="; 
") else paste("ND"))
class <- sapply(1:num.peaks, function(i) if(num.matches[i]>=1) 
paste(unique(db[(met.index[[i]][1:length(met.index[[i]])]), dbclass]), 
collapse="; ") else paste(""))
}
if(x_rt==60) {
print("dbMatch2 assumes 1) rtmedcol is in seconds, the xcms default & 
2) dbrt is in minutes, the MycoMap default. Set x_rt=1 if mzmed is in 
minutes.")
}
data.frame(cbind(x, num.matches, metabolite, class))
}
# Get the fragments from a list of scans that meet specified criteria 
# produces a list
# assign to an object
# output annotated with the scan number
# Tandem MS functions:
# Return the depth of a list
list.depth <- function(this, thisdepth = 0) {
# http://stackoverflow.com/a/13433689/1270695
  if(!is.list(this)) {
    return(thisdepth)
  } else {




ppm <- function (expected, observed) 
{((observed-expected)/expected)*1000000}
# Get all scans from an xcmsRaw MSn=TRUE object or list
# produces a list
# assign to an object
# output annotated with the sample, parent ion and collision energy
peakList <- 
function(xr) {
if(is.list(xr) == FALSE) 
{
lapply(1:length(xr@msnScanindex), function(i) {








if(length(ll)==1) {print("Error: getScan < 2")
}
















if(length(ll)==1) {print("Error: getScan < 2")
}




















if(length(ll)==1) {print("Error: getScan < 2")
}







# Recursively remove nulls from a list 
is.NullOb <- function(x) is.null(x) | all(sapply(x, is.null))
## Recursively step down into list, removing all such objects 
rmNullObs <- function(x) {
   x <- Filter(Negate(is.NullOb), x)
   lapply(x, function(x) if (is.list(x)) rmNullObs(x) else x)
}
# search for fragments using a reference list
peakFrags <- 
function(peak.list, tags, tag.width) {
if(list.depth(peak.list) == 1) {
lapply(1:length(peak.list), function(j) {
lapply(1:dim(peak.list[[j]])[1], function(i) {
if(any(peak.list[[j]][i,2] >= tags - tag.width &
peak.list[[j]][i,2] <= tags + tag.width) == TRUE) {











if(any(peak.list[[k]][[j]][i,2] >= tags - tag.width &
peak.list[[k]][[j]][i,2] <= tags + tag.width) == 
TRUE) {








else {print("peak.list structure not recognized")}
}
peakFragsPPM <- 
function(peak.list, tags, ppmCut) {
if(list.depth(peak.list) == 1) {
lapply(1:length(peak.list), function(j) {
lapply(1:dim(peak.list[[j]])[1], function(i) {





frags <- append(peak.list[[j]][i,], j, 1)
names(frags)[2] <- "scan"
















frags <- append(peak.list[[k]][[j]][i,], j, 1)
names(frags)[2] <- "scan"








else {print("peak.list structure not recognized")}
}
# Make fragmentation plots
# Need a table using the peakList format: requires mz, intensity, massO & 
colO
# Need a vector of reference fragements. Set to the lower limit if not 
needed.
# Add ppm calculations for fragments by setting ppmThresh
# set to < 1 if not desired
# label positions can be adjusted with xadj/yadj
fragPlot <- function(data, limits=c(100, 1800), refFrags, ppmThresh=10, 
ppm_xadj=0, ppm_yadj=0, ppm_labadj=-50, cutoff=FALSE, anno_x=limits[1], 
anno_y=10, anno_xadj=0, anno_yadj=0, mar=c(1,1,1,1), arrow_x=NULL, 
arrow_xend=NULL, arrow_y=NULL, arrow_yend=NULL, ...) {
ppm <- sapply(1:length(refFrags), function(i) abs(ppm(refFrags[i], 
data$mz)))
ppm <- apply(ppm, 1, min)
mzCut <- data.frame(data, ppm)
mzCut <- mzCut[mzCut$ppm <= ppmThresh,]
print(mzCut)
if(is.null(arrow_x))
arrow_x <- rep(0, dim(mzCut)[1])
if(is.null(arrow_xend))
arrow_xend <- rep(0, dim(mzCut)[1])
if(is.null(arrow_y))
arrow_y <- rep(0, dim(mzCut)[1])
if(is.null(arrow_yend))
arrow_yend <- rep(0, dim(mzCut)[1])





geom_vline(xintercept=data$massO[1], color="red", alpha=0.4, 
size=1.1, linetype="dashed") +
annotate("text", x=data$massO[1], y=max(data$intensity)+10, 
label="Parent", size=5, fontface="bold") +
annotate("text", x=anno_x, y=max(data$intensity + 0.05*data
$intensity) + anno_y , label=paste("\nCollision energy = ", data$colO[1], 
"V"), size=5, fontface="bold", hjust=0.075, vjust=0) +
theme(plot.title=element_text(size=16, face="bold"), 
axis.text=element_text(size=16), axis.title.y=element_text(size=16, 
face="bold"), axis.title.x=element_text(size=16, face="bold.italic")) +
xlab("m/z") +
ylab("Intensity") +
ggtitle(paste("Fragmentation of ion", data$massO[1], sep=" ")) +
geom_vline(xintercept=refFrags, color="blue", alpha=0.4, size=1.1, 
linetype="dotted") +
theme(plot.margin = unit(mar, "cm"))
if(is.numeric(ppmThresh) == TRUE) {
ggp <- ggp + annotate("segment", 
x=mzCut$mz + 35 + arrow_x,
xend=mzCut$mz + 10 + arrow_xend,
y=mzCut$intensity + arrow_y,
yend=mzCut$intensity + arrow_yend,
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.75)
}
if(is.numeric(ppmThresh) == TRUE) {
ggp <- ggp +
annotate("text", 
x=mzCut$mz + ppm_xadj + 20, 
y=mzCut$intensity + ppm_yadj + 20,
label=format.AsIs(round(mzCut$mz, 3), nsmall=3), size=5, 
fontface="bold", color="black") +
annotate("text", 
x=mzCut$mz + ppm_xadj + 20, 
y=mzCut$intensity + ppm_yadj + ppm_labadj,
label=paste(format.AsIs(round(mzCut$ppm, 1), nsmall=1), "ppm ", 
sep=" "), size=5, fontface="bold", color="blue") 
}
if(is.numeric(cutoff) == TRUE) {
ggp <- ggp +
annotate("text", x=data$mz[data$intensity > cutoff] + 
anno_xadj, y=data$intensity[data$intensity > cutoff] + anno_yadj + 5, 
label=


























"C50"=803.34719+(1694.17743-1413.90082), # extrapolated from 
PIM2AC1
"C50"=821.35775+(1694.17743-1413.90082), # extrapolated from 
PIM2AC1
"C53"=859.37340+(1694.17743-1413.90082), # extrapolated from 
PIM2AC1







































# Read in MS1 data
# If starting from raw MS data
# peakpicking of negative and positive MS1 data is done by:
# xset_n <- xcmsFun("~/093015JM/Negative")
# xset_n
# xset_p <- xcmsFun("~/093015JM/Positive")
# xset_p
# Save grouped peaks
# pl.xcms_n <- diffreport(xset_n, levels(sampclass(xset_n))[1], 
levels(sampclass(xset_n))[2], eicmax=0, eicwidth=0, sortpval=TRUE, 
value="into", metlin=0.003, filebase="093015_pl_n")
# If starting from the provided diffreport files
# Once the above steps are complete, reload the data with:
# Read in grouped peaks from file
# Read in to convert factors to numeric
pl.xcms_n <- read.table("~/Documents/Projects/Morita_lipidomics/
093015_pl_n.tsv",  colClasses=c(rep("character", 15), rep("numeric", 16)))
paste(dim(pl.xcms_n)[1], "ions were found in the negative mode")
# Note:
# If reading data from Dataset S2, the 
# Repeat for positive mode
# pl.xcms_p <- diffreport(xset_p, levels(sampclass(xset_p))[1], 
levels(sampclass(xset_p))[2], eicmax=0, eicwidth=0, sortpval=TRUE, 
value="into", metlin=0.003, filebase="093015_pl_p")
pl.xcms_p <- read.table("~/Documents/Projects/Morita_lipidomics/
093015_pl_p.tsv", colClasses=c(rep("character", 15), rep("numeric", 16)))
paste(dim(pl.xcms_p)[1], "ions were found in the positive mode")
# Rename for +/- and reformat numbers
pl.xcms_n[,1] <- paste(pl.xcms_n[,1], "n", sep="")














# Quality control monitoring:
# The impounded measurements can be flagged and counted.
metimp_n <- t(sapply(1:dim(pl.xcms_n)[1], function(i) pl.xcms_n[i, 
15:30]==0))
numimp_n <- sapply(1:dim(pl.xcms_n)[1], function(i) 
length(which(metimp_n[i,]=="TRUE")))
lcids_n <- sapply(1:dim(pl.xcms_n)[1], function(i) 
paste(as.character(colnames(pl.xcms_n[, 15:30])[which(pl.xcms_n[i, 
15:30]==0)]), collapse="; "))
metimp_p <- t(sapply(1:dim(pl.xcms_p)[1], function(i) pl.xcms_p[i, 
15:30]==0))
numimp_p <- sapply(1:dim(pl.xcms_p)[1], function(i) 
length(which(metimp_p[i,]=="TRUE")))
lcids_p <- sapply(1:dim(pl.xcms_p)[1], function(i) 
paste(as.character(colnames(pl.xcms_p[, 15:30])[which(pl.xcms_p[i, 
15:30]==0)]), collapse="; "))
# Generate a new table with information about impounded measurements
xcmsImp_n <- data.frame(name=pl.xcms_n$name, number_imp=numimp_n, 
impounded=lcids_n)
xcmsImp_p <- data.frame(name=pl.xcms_p$name, number_imp=numimp_p, 
impounded=lcids_p)
# One sample is impounded 3595 times:
# summary(xcmsImp_p$lcids) # X093015JM57_YM_cw4_p.mzdata 
# summary(xcmsImp_n$lcids) # X093015JM07_YM_f4_n.mzdata is impounded 2620
# Nothing else is close
# both are BioRep 4's
# Biological replicate 4 is of lower quality, but equaly so for PMf and PM-
CW
# Removing it might improve variance, but is not advisable






# add color ramps
 cor.ramp1 <- colorpanel(3, "yellow", "orange", "red")
 cor.ramp2 <- colorpanel(2, "white", "yellow")
 cor.ramp3 <- colorpanel(9, "black", "grey", "white")
 cor.col <- c(cor.ramp3, cor.ramp2, cor.ramp1)
corrplot(pl_p.cor, cl.lim=c(min(pl_p.cor),1), insig="pch", pch=4, 
pch.cex=0.6, type="upper", col=cor.col, method="ellipse", tl.cex=1, 
tl.srt=45, title="Correlation between samples after normalization", 
mar=c(1,0,1,0))
# Need to rename and reorder columns in +/- to match
# Reorder both by sample number and replicate
pl.fq_n <- pl.fq_n[,c(1,4,3,2,7,6,5,8,10,12,11,9,15,16,14,13)]
pl.fq_p <- pl.fq_p[,c(1,2,4,3,7,8,5,6,9:12,15,16,14,13)]
# Pull full file names
files_n <- colnames(pl.fq_n)
files_p <- colnames(pl.fq_p)
files_n <- gsub(".*J", "J", files_n)
files_p <- gsub(".*J", "J", files_p)
files_n <- gsub("_n.mzdata", "", files_n)
files_p <- gsub("_p.mzdata", "", files_p)
files_n <- gsub("_YM_", "", files_n)
files_p <- gsub("_YM_", "", files_p)
fileIds <- paste(files_n, files_p, sep=".")




colnames(pl.cor) <- c("cw1a", "cw2a", "cw3a", "cw4a", "cw1b", "cw2b", 
"cw3b", "cw4b", "f1a",  "f2a",  "f3a",  "f4a", "f1b",  "f2b",  "f3b",  
"f4b")
rownames(pl.cor) <- c("cw1a", "cw2a", "cw3a", "cw4a", "cw1b", "cw2b", 
"cw3b", "cw4b", "f1a",  "f2a",  "f3a",  "f4a", "f1b",  "f2b",  "f3b",  
"f4b")
pl.ord <- c("cw1a", "cw1b", "cw2a", "cw2b", "cw3a", "cw3b", "cw4a", "cw4b",  
"f1a", "f1b", "f2a", "f2b", "f3a", "f3b", "f4a", "f4b")
# add color ramps
 cor.ramp1 <- colorpanel(3, "yellow", "orange", "red")
 cor.ramp2 <- colorpanel(2, "white", "yellow")
 cor.ramp3 <- colorpanel(9, "black", "grey", "white")
 cor.col <- c(cor.ramp3, cor.ramp2, cor.ramp1)
corrplot(pl.cor[pl.ord, pl.ord], cl.lim=c(min(pl.cor),1), insig="pch", 
pch=4, pch.cex=0.6, type="upper", col=cor.col, method="ellipse", tl.cex=1, 
tl.srt=45, title="Correlation between samples after normalization", 
mar=c(1,0,1,0))
# Truncate bottom lipids
# pl.mn <- apply(pl.fq, 1, mean)
# pl.hi <- pl.fq[pl.mn >= 15,]
# pl.corHi <- cor(pl.hi)
# corrplot(pl.corHi[pl.ordHi, pl.ordHi], cl.lim=c(min(pl.corHi),1), 
insig="pch", pch=4, pch.cex=0.6, type="upper", col=cor.col, 
method="ellipse", tl.cex=1, tl.srt=45, title="Correlation between samples 
after normalization", mar=c(1,0,1,0))
# Not driven by low level lipids
# use avearrays to average arrays
pl.fqa <- pl.fq
colnames(pl.fqa) <- c("cw1", "cw2", "cw3", "cw4", "cw1", "cw2", "cw3", 
"cw4", "f1",  "f2",  "f3",  "f4", "f1",  "f2",  "f3",  "f4")
pl.fqa <- avearrays(pl.fqa)
pl_a.cor <- cor(pl.fqa)
pl_a.ord <- c("cw1", "cw2", "cw3", "cw4", "f1", "f2", "f3", "f4")
# add color ramps
 cor.ramp1 <- colorpanel(3, "yellow", "orange", "red")
 cor.ramp2 <- colorpanel(4, "white", "yellow")
 cor.ramp3 <- colorpanel(8, "black", "grey", "white")
 cor.col <- c(cor.ramp3, cor.ramp2, cor.ramp1)
corrplot(pl_a.cor[pl_a.ord, pl_a.ord], cl.lim=c(min(pl_a.cor),1), 
insig="pch", pch=4, pch.cex=0.6, type="lower", col=cor.col, 
method="ellipse", tl.cex=1, tl.srt=45, title="Correlation between samples 
after normalization", mar=c(1,0,1,0))




# rename and split names into design matrix
targets.a <- data.frame(name=colnames(pl.fqa))
targets.a[,2] <- substr(targets.a[,1], nchar(as.character(targets.a[,
1]))-2, nchar(as.character(targets.a[,1]))-1)
targets.a[,3] <- substr(targets.a[,1], nchar(as.character(targets.a[,1])), 
nchar(as.character(targets.a[,1]))+1)
names(targets.a) <- c("Name", "Fraction", "BioRep")
fraction <- as.numeric(factor(targets.a$Fraction))
biorep <- as.numeric(factor(targets.a$BioRep))
# Now build a model matrix
design <- model.matrix(~ fraction + biorep)
# design
# Use limma to build, fit and test a model
fit <- lmFit(pl.fqa, design)
fit <- eBayes(fit)
tT_pl <- topTable(fit, coef="fraction", number=dim(fit$t)[1])
results <- decideTests(fit)
sum <- summary(results)
# QC: a QQ-plot
par(mar=c(7,7,7,7))
qqt(fit$t[,2], main="QQ-Plot, Paired Sample X Fraction")
abline(0,1)
# Looks good.
# Build a fully annotated object
# Stats in tT_pl; intensities in pl.fq & pl.fqa; mz and rt in pl.xcms;
# information about impounded measurements is in xcmsImp_n
# Add putative ids from MycoMap and MycoMass
# Add impounded flags to xcms summary stats
pl.ss_n <- merge(pl.xcms_n[,1:13], xcmsImp_n, by.x=1, by.y=1)
pl.ss_p <- merge(pl.xcms_p[,1:13], xcmsImp_p, by.x=1, by.y=1)
# An xcms summary object
xcmsStats <- rbind(pl.ss_n, pl.ss_p)
# Add xcms to tT object
tT_xcms <- merge(tT_pl, xcmsStats, by.x=0, by.y=1)
# Add peak intensities to the topTable
tT_pia <- merge(tT_xcms, pl.fqa, by.x=1, by.y=0)
tT_pi <- merge(tT_pia, pl.fq, by.x=1, by.y=0)
# Output full table of information





# A note about database matching:
# Matches between ions and the m/z and/or retention time of a known 
compound
# are putative at best.
# Database matching is performed below only to choose targets
# that are subsequently validated by tandem MS.
# MycoMap and MycoMass are available at:
# http://www.brighamandwomens.org/research/depts/medicine/rheumatology/
Labs/Moody/default.aspx
# Note: the downloaded versions must be curated to R readable versions
# by changing the names and saving as .csv, etc
# ie names(MycoMap)
# > names(MycoMap)
# [1] "Class"             "Subclass"          "Formula"          
# [4] "Detected.m_z"      "Ion_mode"          "Calculated_mz_pos"
# [7] "Calculated_mz_neg" "Dm_amu"            "RT_min"           
# [10] "RT_min2"           "RT_dev"           
# Match to mass and retention time
# MycoMap matching
MycoMap <- read.csv("~/Documents/Projects/Morita_lipidomics/MycoMap_R.csv", 
header=TRUE)
 
tT_ID.n <- dbMatch_2(tT_pi[substr(tT_pi[,1], nchar(as.character(tT_pi[,
1])), nchar(as.character(tT_pi[,1]))+1) == "n",], mzmedcol=11, db=MycoMap, 
dbnames=1, dbclass=3, dbcol=7, rtmedcol=14, dbrt=9, rt_tolerance=8)
tT_ID.p <- dbMatch_2(tT_pi[substr(tT_pi[,1], nchar(as.character(tT_pi[,
1])), nchar(as.character(tT_pi[,1]))+1) == "p",], mzmedcol=11, db=MycoMap, 
dbnames=1, dbclass=3, dbcol=6, rtmedcol=14, dbrt=9, rt_tolerance=8)
tT_ID <- rbind(tT_ID.n, tT_ID.p)
# Annotate by MycoMass
MycoMass <- read.csv("~/Documents/Projects/Moody/MycoMass_R.csv", 
header=TRUE)
names(MycoMass)[1:8] <- c("Abbreviation", "Mass", "[M+H]+", "[M+NH4]+", "[M
+Na]+", "[M-H]-", "[M+HCOO]-", "[M+CH3COO]-")
tT_An <- dbMatch(tT_ID[substr(tT_ID[,1], nchar(as.character(tT_ID[,1])), 
nchar(as.character(tT_ID[,1]))+1) == "n",], 11, MycoMass, 9, 13, 6:8)
tT_Ap <- dbMatch(tT_ID[substr(tT_ID[,1], nchar(as.character(tT_ID[,1])), 
nchar(as.character(tT_ID[,1]))+1) == "p",], 11, MycoMass, 9, 13, 3:5)
tT_An <- rbind(tT_An, tT_Ap)
# Who has MycoMap matches
tT_wID <- tT_ID[(tT_ID$num.matches != 0),]
tT_wID[,c(1:2,11,47)]
# Who has MycoMass matches
tT_wAn <- tT_An[(tT_An$num.matches.1 != 0),]
tT_wAn[,c(1:3,6,11,50:51)]
tT_wAn[,c(1,50)]
# Add intensity, fc, qc cutoffs
# tT lfc: - is PM-CW, + is PMf






# color flag set to 2-fold change
cf <- tT_pl[abs(tT_pl$logFC) >=1 & tT_pl$adj.P.Val <=0.05, ]
made.cut <- cbind(PMf.up=sum(tT_pl$logFC >=1 & tT_pl$adj.P.Val <=0.05),
PMCW.up=sum(tT_pl$logFC <=-1 & tT_pl$adj.P.Val <=0.05),





PE <- tT_pl[row.names(tT_pl)=="M733T1200n", ]
PIM3Ac1 <- tT_pl[row.names(tT_pl)=="M1576T1991n", ] # C51:0
PA_671 <- tT_pl[row.names(tT_pl)=="M671T454n", ]
PA_673 <- tT_pl[row.names(tT_pl)=="M673T428n", ]
# More map points
PA_645 <- tT_pl[row.names(tT_pl)=="M645T457n", ]
PA_675 <- tT_pl[row.names(tT_pl)=="M675T419n", ]
TAG_850 <- tT_pl[row.names(tT_pl)=="M851T183p", ]
TAG_865 <- tT_pl[row.names(tT_pl)=="M865T360p", ]
TAG_879 <- tT_pl[row.names(tT_pl)=="M879T185p", ]
TAG_906 <- tT_pl[row.names(tT_pl)=="M907T184p", ]
PI_851 <- tT_pl[row.names(tT_pl)=="M852T1484n", ]
PE_715 <- tT_pl[row.names(tT_pl)=="M715T1159n", ]
PE_686 <- tT_pl[row.names(tT_pl)=="M686T1174n", ]
PE_716 <- tT_pl[row.names(tT_pl)=="M717T1192n", ]
DAG_612 <- tT_pl[row.names(tT_pl)=="M613T185p", ]
Ac2PIM_1492 <- tT_pl[row.names(tT_pl)=="M1492T1504p", ] # C67:0
Ac2PIM2_1671 <- tT_pl[row.names(tT_pl)=="M1671T1501p", ] # C67:0




# pdf("~/Documents/Projects/Moody/Yasu/YM_Figure2a.pdf", family="ArialMT", 
height=6.83, width=6.83)
ggplot(tT_pl, aes(x=logFC, y=-log10(adj.P.Val), color=AveExpr)) +
geom_point(shape=1) +
scale_color_gradient(low="grey", high="black", name="Intensity\n 
(log2)") +
















xlab(paste("  Fold change (log2)")) +
ylab("Significance (-log10 p value)") +
ggtitle(paste(made.cut[2], "up in PM-CW", "        n =", made.cut[4], 
"              ", made.cut[1], "up in PMf",  sep=" ")) +
geom_point(data=PE, aes(x=PE$logFC, yend=-log10(PE$adj.P.Val), color=PE
$AveExpr), shape=16) +
annotate("segment", x=PE$logFC-1.8, xend=PE$logFC-0.3, y=-log10(PE
$adj.P.Val), yend=-log10(PE$adj.P.Val), arrow=arrow(length=unit(0.2, 
"cm")), color="white", size=1) +
annotate("segment", x=PE$logFC-1.8, xend=PE$logFC-0.3, y=-log10(PE
$adj.P.Val), yend=-log10(PE$adj.P.Val), arrow=arrow(length=unit(0.2, 
"cm")), color="black", size=0.7) +
annotate("text", x=PE$logFC, y=-log10(PE$adj.P.Val)-0.035, 
label=paste("PE C35:0 (B)"), size=5.5, hjust=1.35, fontface="bold") +
geom_point(data=PIM3Ac1, aes(x=PIM3Ac1$logFC, yend=-
log10(PIM3Ac1$adj.P.Val), color=PIM3Ac1$AveExpr), shape=16) +
annotate("segment", x=PIM3Ac1$logFC-1.8, xend=PIM3Ac1$logFC-0.3, y=-
log10(PIM3Ac1$adj.P.Val), yend=-log10(PIM3Ac1$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PIM3Ac1$logFC-1.8, xend=PIM3Ac1$logFC-0.3, y=-
log10(PIM3Ac1$adj.P.Val), yend=-log10(PIM3Ac1$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PIM3Ac1$logFC, y=-log10(PIM3Ac1$adj.P.Val), 
label=paste("AcPIM3 C51:0 (D)"), size=5.5, hjust=1.25, fontface="bold") +
geom_point(data=PA_671, aes(x=PA_671$logFC, yend=-
log10(PA_671$adj.P.Val), color=PA_671$AveExpr), shape=16) +
annotate("segment", x=PA_671$logFC+1.8, xend=PA_671$logFC+0.3, y=-
log10(PA_671$adj.P.Val), yend=-log10(PA_671$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PA_671$logFC+1.8, xend=PA_671$logFC+0.3, y=-
log10(PA_671$adj.P.Val), yend=-log10(PA_671$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PA_671$logFC, y=-log10(PA_671$adj.P.Val), 
label=paste("PA C34:2 (F)"), size=5.5, hjust=-0.35, fontface="bold") +
geom_point(data=PA_673, aes(x=PA_673$logFC, yend=-
log10(PA_673$adj.P.Val), color=PA_673$AveExpr), shape=16) +
annotate("segment", x=PA_673$logFC+1.8, xend=PA_673$logFC+0.3, y=-
log10(PA_673$adj.P.Val)-0.04, yend=-log10(PA_673$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PA_673$logFC+1.8, xend=PA_673$logFC+0.3, y=-
log10(PA_673$adj.P.Val)-0.04, yend=-log10(PA_673$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PA_673$logFC, y=-log10(PA_673$adj.P.Val)-0.04, 
label=paste("PA C34:1"), size=5.5, hjust=-0.5, fontface="bold") +
geom_point(data=PA_645, aes(x=PA_645$logFC, yend=-
log10(PA_645$adj.P.Val), color=PA_645$AveExpr), shape=16) +
annotate("segment", x=PA_645$logFC+1.8, xend=PA_645$logFC+0.3, y=-
log10(PA_645$adj.P.Val)+0.04, yend=-log10(PA_645$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PA_645$logFC+1.8, xend=PA_645$logFC+0.3, y=-
log10(PA_645$adj.P.Val)+0.04, yend=-log10(PA_645$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PA_645$logFC, y=-log10(PA_645$adj.P.Val)+0.04, 
label=paste("PA C32:1"), size=5.5, hjust=-0.5, fontface="bold") +
geom_point(data=PA_675, aes(x=PA_675$logFC, yend=-
log10(PA_675$adj.P.Val), color=PA_675$AveExpr), shape=16) +
annotate("segment", x=PA_675$logFC+1.8, xend=PA_675$logFC+0.3, y=-
log10(PA_675$adj.P.Val)+0.04, yend=-log10(PA_675$adj.P.Val)+0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PA_675$logFC+1.8, xend=PA_675$logFC+0.3, y=-
log10(PA_675$adj.P.Val)+0.04, yend=-log10(PA_675$adj.P.Val)+0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PA_675$logFC, y=-log10(PA_675$adj.P.Val)+0.04, 
label=paste("PA C34:0"), size=5.5, hjust=-0.5, fontface="bold") +
geom_point(data=TAG_850, aes(x=TAG_850$logFC, yend=-
log10(TAG_850$adj.P.Val), color=TAG_850$AveExpr), shape=16) +
annotate("segment", x=TAG_850$logFC+1.8, xend=TAG_850$logFC+0.3, y=-
log10(TAG_850$adj.P.Val)+0.05, yend=-log10(TAG_850$adj.P.Val)+0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=TAG_850$logFC+1.8, xend=TAG_850$logFC+0.3, y=-
log10(TAG_850$adj.P.Val)+0.05, yend=-log10(TAG_850$adj.P.Val)+0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=TAG_850$logFC, y=-log10(TAG_850$adj.P.Val)+0.05, 
label=paste("TAG C50:1"), size=5.5, hjust=-0.4, fontface="bold") +
geom_point(data=TAG_865, aes(x=TAG_865$logFC, yend=-
log10(TAG_865$adj.P.Val), color=TAG_865$AveExpr), shape=16) +
annotate("segment", x=TAG_865$logFC+1.8, xend=TAG_865$logFC+0.3, y=-
log10(TAG_865$adj.P.Val)-0.03, yend=-log10(TAG_865$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=TAG_865$logFC+1.8, xend=TAG_865$logFC+0.3, y=-
log10(TAG_865$adj.P.Val)-0.03, yend=-log10(TAG_865$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=TAG_865$logFC, y=-log10(TAG_865$adj.P.Val)-0.03, 
label=paste("TAG C51:1"), size=5.5, hjust=-0.45, fontface="bold") +
geom_point(data=TAG_879, aes(x=TAG_879$logFC, yend=-
log10(TAG_879$adj.P.Val), color=TAG_879$AveExpr), shape=16) +
annotate("segment", x=TAG_879$logFC+1.8, xend=TAG_879$logFC+0.3, y=-
log10(TAG_879$adj.P.Val)-0.07, yend=-log10(TAG_879$adj.P.Val)-0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=TAG_879$logFC+1.8, xend=TAG_879$logFC+0.3, y=-
log10(TAG_879$adj.P.Val)-0.07, yend=-log10(TAG_879$adj.P.Val)-0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=TAG_879$logFC, y=-log10(TAG_879$adj.P.Val)-0.07, 
label=paste("TAG C52:1 (E)"), size=5.5, hjust=-0.3, fontface="bold") +
geom_point(data=TAG_906, aes(x=TAG_906$logFC, yend=-
log10(TAG_906$adj.P.Val), color=TAG_906$AveExpr), shape=16) +
annotate("segment", x=TAG_906$logFC+1.8, xend=TAG_906$logFC+0.3, y=-
log10(TAG_906$adj.P.Val), yend=-log10(TAG_906$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=TAG_906$logFC+1.8, xend=TAG_906$logFC+0.3, y=-
log10(TAG_906$adj.P.Val), yend=-log10(TAG_906$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=TAG_906$logFC, y=-log10(TAG_906$adj.P.Val), 
label=paste("TAG C54:1"), size=5.5, hjust=-0.4, fontface="bold") +
geom_point(data=PI_851, aes(x=PI_851$logFC, yend=-
log10(PI_851$adj.P.Val), color=PI_851$AveExpr), shape=16) +
annotate("segment", x=PI_851$logFC+1.8, xend=PI_851$logFC+0.3, y=-
log10(PI_851$adj.P.Val), yend=-log10(PI_851$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PI_851$logFC+1.8, xend=PI_851$logFC+0.3, y=-
log10(PI_851$adj.P.Val), yend=-log10(PI_851$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PI_851$logFC, y=-log10(PI_851$adj.P.Val), 
label=paste("PI C35:0 (C)"), size=5.5, hjust=-0.4, fontface="bold") +
geom_point(data=PE_715, aes(x=PE_715$logFC, yend=-
log10(PE_715$adj.P.Val), color=PE_715$AveExpr), shape=16) +
annotate("segment", x=PE_715$logFC-1.8, xend=PE_715$logFC-0.3, y=-
log10(PE_715$adj.P.Val)+0.03, yend=-log10(PE_715$adj.P.Val)+0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PE_715$logFC-1.8, xend=PE_715$logFC-0.3, y=-
log10(PE_715$adj.P.Val)+0.03, yend=-log10(PE_715$adj.P.Val)+0.01, 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PE_715$logFC, y=-log10(PE_715$adj.P.Val)+0.03, 
label=paste("PE C34:2"), size=5.5, hjust=1.5, fontface="bold") +
geom_point(data=PE_686, aes(x=PE_686$logFC, yend=-
log10(PE_686$adj.P.Val), color=PE_686$AveExpr), shape=16) +
annotate("segment", x=PE_686$logFC-1.8, xend=PE_686$logFC-0.3, y=-
log10(PE_686$adj.P.Val)-0.13, yend=-log10(PE_686$adj.P.Val)-0.03, 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PE_686$logFC-1.8, xend=PE_686$logFC-0.3, y=-
log10(PE_686$adj.P.Val)-0.13, yend=-log10(PE_686$adj.P.Val)-0.03, 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PE_686$logFC, y=-log10(PE_686$adj.P.Val)-0.13, 
label=paste("PE C32:2"), size=5.5, hjust=1.5, fontface="bold") +
geom_point(data=PE_716, aes(x=PE_716$logFC, yend=-
log10(PE_716$adj.P.Val), color=PE_716$AveExpr), shape=16) +
annotate("segment", x=PE_716$logFC+1.8, xend=PE_716$logFC+0.3, y=-
log10(PE_716$adj.P.Val)-0.14, yend=-log10(PE_716$adj.P.Val)-0.03, 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=PE_716$logFC+1.8, xend=PE_716$logFC+0.3, y=-
log10(PE_716$adj.P.Val)-0.14, yend=-log10(PE_716$adj.P.Val)-0.03, 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=PE_716$logFC, y=-log10(PE_716$adj.P.Val)-0.14, 
label=paste("PE C34:1"), size=5.5, hjust=-0.5, fontface="bold") +
geom_point(data=DAG_612, aes(x=DAG_612$logFC, yend=-
log10(DAG_612$adj.P.Val), color=DAG_612$AveExpr), shape=16) +
annotate("segment", x=DAG_612$logFC+1.8, xend=DAG_612$logFC+0.3, y=-
log10(DAG_612$adj.P.Val), yend=-log10(DAG_612$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="white", size=1) +
annotate("segment", x=DAG_612$logFC+1.8, xend=DAG_612$logFC+0.3, y=-
log10(DAG_612$adj.P.Val), yend=-log10(DAG_612$adj.P.Val), 
arrow=arrow(length=unit(0.2, "cm")), color="black", size=0.7) +
annotate("text", x=DAG_612$logFC, y=-log10(DAG_612$adj.P.Val), 
label=paste("DAG C34:1"), size=5.5, hjust=-0.5, fontface="bold") +
geom_point(data=Ac2PIM_1492, aes(x=Ac2PIM_1492$logFC, yend=-
log10(Ac2PIM_1492$adj.P.Val), color=Ac2PIM_1492$AveExpr), shape=16) +
annotate("segment", x=Ac2PIM_1492$logFC-1.8, 
xend=Ac2PIM_1492$logFC-0.3, y=-log10(Ac2PIM_1492$adj.P.Val)+0.11, yend=-




log10(Ac2PIM_1492$adj.P.Val)+0.03, arrow=arrow(length=unit(0.2, "cm")), 
color="black", size=0.7) +
annotate("text", x=Ac2PIM_1492$logFC, y=-log10(Ac2PIM_1492$adj.P.Val)
+0.11, label=paste("Ac2PIM C67:0"), size=5.5, hjust=1.35, fontface="bold") 
+
geom_point(data=Ac2PIM2_1671, aes(x=Ac2PIM2_1671$logFC, yend=-
log10(Ac2PIM2_1671$adj.P.Val), color=Ac2PIM2_1671$AveExpr), shape=16) +
annotate("segment", x=Ac2PIM2_1671$logFC-1.8, 
xend=Ac2PIM2_1671$logFC-0.3, y=-log10(Ac2PIM2_1671$adj.P.Val)-0.1, yend=-




log10(Ac2PIM2_1671$adj.P.Val)-0.03, arrow=arrow(length=unit(0.2, "cm")), 
color="black", size=0.7) +
annotate("text", x=Ac2PIM2_1671$logFC, y=-
log10(Ac2PIM2_1671$adj.P.Val)-0.1, label=paste("Ac2PIM2 C67:0"), size=5.5, 
hjust=1.3, fontface="bold") +
geom_point(data=Ac2PIM2_1713, aes(x=Ac2PIM2_1713$logFC, yend=-
log10(Ac2PIM2_1713$adj.P.Val), color=Ac2PIM2_1713$AveExpr), shape=16) +
annotate("segment", x=Ac2PIM2_1713$logFC-1.8, 
xend=Ac2PIM2_1713$logFC-0.3, y=-log10(Ac2PIM2_1713$adj.P.Val), yend=-




log10(Ac2PIM2_1713$adj.P.Val), arrow=arrow(length=unit(0.2, "cm")), 
color="black", size=0.7) +
annotate("text", x=Ac2PIM2_1713$logFC, y=-






# Summary table for keystone lipids
# Add more info from MycoMap
tT_wFullID <- merge(tT_wID, MycoMap, by.x=48, by.y=3)
# Filter classes w/o CID and info not needed
tT_wFullID <- tT_wFullID[,c(2:4,7,12,1,49:50, 52:54)]
tT_wFullID <- tT_wFullID[grepl("glyce",tT_wFullID[,7]) |
grepl("phos",tT_wFullID[,7]),]
tT_wFullID <- tT_wFullID[!grepl("lyso",tT_wFullID[,8]),]








# Read in hits from volcano
volHits <- rbind(DAG_612, PA_645, PA_671, PA_673, PA_675, PE_686, PE_715, 
PE_716, PE, PI_851, Ac2PIM_1492, Ac2PIM2_1671, Ac2PIM2_1713, PIM3Ac1, 
TAG_850, TAG_865, TAG_879, TAG_906)
# Remove MycoMap matches
sT_woMycoMap <- unique(tT_An[tT_An[,1] %in% row.names(volHits)[!
row.names(volHits) %in% tT_wFullID[,1]],c(1:3, 6, 11, 50:51)])
names(sT_woMycoMap)[6:7] <- c("Class", "Formula")
sT_wMycoMass <- merge(sT_woMycoMap, MycoMass, all.x=TRUE, sort=FALSE) # 
None need a subclass
# but do need the calculated_mz
sT_wMycoMass_mz <- c(sT_wMycoMass[1:5,13], sT_wMycoMass[6,10], 
sT_wMycoMass[7:8,11])




# Merge hits with CID and those with MycoMap matches only
sumTab <- merge(tT_wFullID, sT_woMycoMap, all.x=TRUE, all.y=TRUE)
sumTab$CID <- sumTab$Row.names %in% row.names(volHits)
# fix, shorten names
sumTab$Class <- gsub("phosphatidyl- ethanolamine", 
"phosphatidylethanolamine", sumTab$Class)
sumTab$Class <- gsub("phosphatidyl-ethanolamine", 
"phosphatidylethanolamine", sumTab$Class)
sumTab$Class <- gsub("phosphatidyl- inositol", "phosphatidylinositol", 
sumTab$Class)
sumTab$Class <- gsub("phosphatidyl-  inositol", "phosphatidylinositol", 
sumTab$Class)
sumTab$Class <- gsub("phosphatidy-  inositol", "phosphatidylinositol", 
sumTab$Class)
sumTab$Class <- gsub("phosphatidy- inositol", "phosphatidylinositol", 
sumTab$Class)
sumTab$Class <- gsub("phosphatidylethanolamines", 
"phosphatidylethanolamine", sumTab$Class)
sumTab$Class <- gsub("phosphatidyl-myo-inositol-dimannosides", 
"phosphatidylinositol dimannoside", sumTab$Class)
sumTab$Class <- gsub("phosphatidyl-myo-inositol-monomannosides", 
"phosphatidylinositol monomannosides", sumTab$Class)
sumTab$Class <- gsub("phosphatidyl-myo-inositol-monomannosides", 
"phosphatidylinositol monomannosides", sumTab$Class)
sumTab$Ion_mode <- gsub("pos/", "", sumTab$Ion_mode)
sumTab$Ion_mode <- gsub("neg/", "", sumTab$Ion_mode)
sumTab$CID <- gsub("FALSE", "N", sumTab$CID)
sumTab$CID <- gsub("TRUE", "Y", sumTab$CID)






# Reorder and rename
sumTab <- sumTab[,c(7,10,6,1,9,5,12,8,11,2,4,3)]
names(sumTab) <- c("Class", "Subclass", "Formula", "xcms Name", "Expected 
m/z", "Observed m/z", "Deviation (ppm)", "Ion", "CID", "Fold change 
(log2)", "Adjusted P value", "Average normalized intensity")
sumTab <- sumTab[order(sumTab$Class),]
# Fix subclass
sumTab$Subclass[is.na(sumTab$Subclass) & grepl("inositol", sumTab$Class)] 
<- "diacyl"
sumTab$Subclass[is.na(sumTab$Subclass)] <- ""
# Filter redundant rows
# TAGs with 300 s retention times are too late and 100 s times should be 
used
# positive mode PIMs with CID should be used over negative mode w/o
sumTab <- sumTab[!sumTab$"xcms Name" %in% c("M852T1622n", "M851T366p", 
"M865T360p", "M879T364p", "M907T361p", "M963T367p", "M1652T1485n", 
"M1694T1462n"),]
sumTab




# Tandem MS analysis
# If starting from raw MSMS data




# xr <- sapply(1:length(mzdatafiles), function(i) xcmsRaw(mzdatafiles[i], 
includeMSn=TRUE))
# saveRDS(xr, "Morita_XCMSRaw")
# If starting from the provided RDS file
xr <- readRDS("~/Documents/Projects/Morita_lipidomics/Morita_XCMSRaw")
# Get parents and scans
# Get all Msn scans
peak.list <- peakList(xr) 
# To match measured fragments to calculated fragments, use a database
# of expected fragments based on MycoMap.





peak.list.pe <- peakList(xr[[4]]) 
peak.frags.pe <- peakFragsPPM(peak.list.pe, tags=MyMapFrags$PE.n$fragments, 
ppmCut=10)
# Clean the list by removing null scans
found.frags.pe <- rmNullObs(peak.frags.pe)
# Split the nested list into a single data frame
found.frags.pe <- unlist(found.frags.pe, recursive=FALSE)
all.frags.pe <- t(sapply(1:length(found.frags.pe), function(i) 
found.frags.pe[[i]]))
# scans meeting fragmentation criteria, ie same parent, collision energy, 
etc
setList.pe <- all.frags.pe[(all.frags.pe[,6] >= 732.4 &
 all.frags.pe[,6] <= 732.7)  # same parent mass




refFrags.pe <- c(as.numeric(MyMapFrags$PE.n$parent), as.numeric(MyMapFrags
$PE.n$fragments))
# pdf("~/YM_FigureS5.pdf", family="ArialMT", height=6.83, width=6.83)
fragPlot(as.data.frame(peak.list.pe[[828]]), limits=c(100, 740), 
refFrags=refFrags.pe[-1], ppmThresh=10, ppm_xadj=60, ppm_yadj=c(-100, 0, 




# Use the alkane series to find more PEs, PI
PEhead.alkane <- as.numeric(MyMapFrags$PA_series.n
$fragments[-1]+197.045309488)
refFrags.pe_series <- c(140.01182, 196.038, MyMapFrags$PA_series.n
$fragments[-1], PEhead.alkane)
# Look for all PEs
peak.list.pe2 <- lapply(5:7, function(i) peakList(xr[[i]])) 
PEhead.alkane <- as.numeric(MyMapFrags$PA_series.n
$fragments[-1]+197.045309488)
refFrags.pe_series <- c(140.01182, 196.038, MyMapFrags$PA_series.n
$fragments[-1], PEhead.alkane)
peak.frags.pes <- peakFragsPPM(peak.list.pe2, tags=refFrags.pe_series, 
ppmCut=15)
found.frags.pes <- rmNullObs(peak.frags.pes)
# Split the nested list into a single data frame
found.frags.pes <- unlist(found.frags.pes, recursive=FALSE)
found.frags.pes <- unlist(found.frags.pes, recursive=FALSE)
all.frags.pes <- t(sapply(1:length(found.frags.pes), function(i) 
found.frags.pes[[i]]))
f.scan <- paste(all.frags.pes[,1], all.frags.pes[,2], sep="_")
mulFrags.pes <- all.frags.pes[duplicated(f.scan) | duplicated(f.scan, 
fromLast=TRUE),]
setList.pes <- mulFrags.pes[mulFrags.pes[,9] >= 1000 &
 mulFrags.pes[,9] <= 2000,]
setList.pesID <- dbMatch(setList.pes, 6, MycoMass, 1, 2, 6:8, 
mass_tolerance=0.02)
setList.pesID[grepl("PE", setList.pesID[,11]),]
# Lots of PE 732
# Good enough 686
fragPlot(as.data.frame(peak.list.pe2[[1]][[850]]), limits=c(100, 775), 
refFrags=refFrags.pe_series, ppmThresh=30, mar=c(1,1,1,0))
# support
fragPlot(as.data.frame(peak.list.pe2[[1]][[851]]), limits=c(100, 775), 
refFrags=refFrags.pe_series, ppmThresh=30, mar=c(1,1,1,0))
# Good enough.  PE 714
fragPlot(as.data.frame(peak.list.pe2[[2]][[954]]), limits=c(100, 775), 
refFrags=refFrags.pe_series, ppmThresh=30, mar=c(1,1,1,0))
# Good! Add PE 716
fragPlot(as.data.frame(peak.list.pe2[[3]][[1284]]), limits=c(100, 775), 
refFrags=refFrags.pe_series, ppmThresh=30, mar=c(1,1,1,0))
# support




peak.list.pi <- peakList(xr[[6]]) 
peak.frags.pi <- peakFragsPPM(peak.list.pi, tags=MyMapFrags$PI.n$fragments, 
ppmCut=10)
found.frags.pi <- rmNullObs(peak.frags.pi)
# Split the nested list into a single data frame
found.frags.pi <- unlist(found.frags.pi, recursive=FALSE)
all.frags.pi <- t(sapply(1:length(found.frags.pi), function(i) 
found.frags.pi[[i]]))
f.scan <- paste(all.frags.pi[,1], all.frags.pi[,2], sep="_")
mulFrags.pi <- all.frags.pi[duplicated(f.scan) | duplicated(f.scan, 
fromLast=TRUE),]
setList.pi <- mulFrags.pi[(mulFrags.pi[,9] >= 1200 &





fragPlot(as.data.frame(peak.list.pi[[936]]), limits=c(140, 900), 
refFrags=refFrags.pi, ppmThresh=10, ppm_labadj=-40, 
ppm_xadj=c(-90,-70, 70, 70, 70),
ppm_yadj=c(150, 165, 0, 0, 0),
arrow_x=c(-80,-60, 0, 0, 0),
arrow_xend=c(-13, -13, 0, 0, 0),









peak.frags.PIM3Ac1 <- peakFragsPPM(peak.list.pimN, tags=MyMapFrags
$PIM3Ac1$fragments, ppmCut=10)
found.frags.PIM3Ac1 <- rmNullObs(peak.frags.PIM3Ac1)
# Split the nested list into a single data frame
found.frags.PIM3Ac1 <- unlist(found.frags.PIM3Ac1, recursive=FALSE)
all.frags.PIM3Ac1 <- t(sapply(1:length(found.frags.PIM3Ac1), function(i) 
found.frags.PIM3Ac1[[i]]))
# scans meeting fragmentation criteria, ie same parent, collision energy, 
etc
setList.PIM3Ac1 <- all.frags.PIM3Ac1[(all.frags.PIM3Ac1[,6] >= 1575.934 &
 all.frags.PIM3Ac1[,6] <= 1575.974) # same parent mass
 # & all.frags.acpim3[,6] == 35 # same collision energy
,]
setList.PIM3Ac1
# pdf("~/YM_FigureS7.pdf", family="ArialMT", height=6.83, width=6.83)












peak.list.pimP <- lapply(1:3, function(i) peakList(xr[[i]])) 
PIMp.parents <- unlist(MycoMass[grepl("PIM", MycoMass
$Abbreviation),c(3:5)])
PIMdelR2 <- c(551.503387058, 579.534687186, 593.550337251, 1492.09221, 
1270.88910, 1671.17159, 1713.21854, 1861.25571)
peak.pimp  <- peakFragsPPM(peak.list.pimP, tags=PIMdelR2, ppmCut=10)
found.frags.pimp <- rmNullObs(peak.pimp)
found.frags.pimp <- unlist(found.frags.pimp, recursive=FALSE)
found.frags.pimp <- unlist(found.frags.pimp, recursive=FALSE)
all.frags.pimp <- t(sapply(1:length(found.frags.pimp), function(j) 
found.frags.pimp[[j]]))
setList.pimp <- all.frags.pimp[all.frags.pimp[,9] <= 2400 & 
all.frags.pimp[,9] >= 1200,]
setList.pimp
PIMp.list <- sapply(1:length(PIMp.parents), function(i) 
setList.pimp[setList.pimp[,6] <= PIMp.parents[i] + 0.03 & setList.pimp[,6] 
>= PIMp.parents[i] - 0.03,])
PIMp.list <- rmNullObs(PIMp.list)
# Ac2PIM1 [H+] 1492.092
refFrags_1492 <- c(1492.09221, PIMdelR2[1:3])
fragPlot(as.data.frame(peak.list.pimP[[1]][[173]]), limits=c(140, 1525), 
refFrags=refFrags_1492)
# AcPIM1 [NH4+] 1270.889
refFrags_1270 <- c(1270.88910, PIMdelR2)
fragPlot(as.data.frame(peak.list.pimP[[2]][[237]]), limits=c(140, 1300), 
refFrags=refFrags_1270)
# Has AcPIM but also CL! Not useable
# Ac2PIM2 [NH4+] 1671.172
refFrags_1671 <- c(1671.17159, PIMdelR2)
fragPlot(as.data.frame(peak.list.pimP[[3]][[161]]), limits=c(140, 1700), 
refFrags=refFrags_1671)
# Ac2PIM2 [NH4+] 1713.219
refFrags_1713 <- c(1713.21854, PIMdelR2)





peak.frags.pa <- peakFragsPPM(peak.list.pa, tags=MyMapFrags$PA_673.n
$fragments, ppmCut=10)
found.frags.pa <- rmNullObs(peak.frags.pa)
# Split the nested list into a single data frame
found.frags.pa <- unlist(found.frags.pa, recursive=FALSE)
all.frags.pa <- t(sapply(1:length(found.frags.pa), function(i) 
found.frags.pa[[i]]))
setList.pa <- all.frags.pa[(all.frags.pa[,6] >= 671 &
 all.frags.pa[,6] <= 674)
 & (all.frags.pa[,9] >= 421 &
 all.frags.pa[,9] <= 479),]
setList.pa
refFrags.pa_671 <- c(as.numeric(MyMapFrags$PA_671.n$parent), 
as.numeric(MyMapFrags$PA_671.n$fragments))
refFrags.pa_673 <- c(as.numeric(MyMapFrags$PA_673.n$parent), 
as.numeric(MyMapFrags$PA_673.n$fragments))










# pdf("~/YM_FigureS9.pdf", family="ArialMT", height=6.83, width=6.83)










# repeat for all PAs
peak.frags.pa2 <- peakFragsPPM(peak.list.pa, tags=MyMapFrags$PA_series.n
$fragments, ppmCut=10)
found.frags.pa2 <- rmNullObs(peak.frags.pa2)
# Split the nested list into a single data frame
found.frags.pa2 <- unlist(found.frags.pa2, recursive=FALSE)
all.frags.pa2 <- t(sapply(1:length(found.frags.pa2), function(i) 
found.frags.pa2[[i]]))
f.scan <- paste(all.frags.pa2[,1], all.frags.pa2[,2], sep="_")
mulFrags.pa <- all.frags.pa2[duplicated(f.scan) | duplicated(f.scan, 
fromLast=TRUE),]
setList.pa <- mulFrags.pa[(mulFrags.pa[,3] >= 152.9 &
 mulFrags.pa[,3] <= 153) & (mulFrags.pa[,9] >= 100 &
 mulFrags.pa[,9] <= 800),]
setList.pa
# Looks good.  Refine labels
# 645
fragPlot(as.data.frame(peak.list.pa[[477]]), limits=c(140, 675), 
refFrags=as.numeric(MyMapFrags$PA_series.n$fragments))
# or
fragPlot(as.data.frame(peak.list.pa[[478]]), limits=c(140, 675), 
refFrags=as.numeric(MyMapFrags$PA_series.n$fragments))
# or
fragPlot(as.data.frame(peak.list.pa[[494]]), limits=c(140, 675), 
refFrags=as.numeric(MyMapFrags$PA_series.n$fragments))
# 689
fragPlot(as.data.frame(peak.list.pa[[541]]), limits=c(140, 700), 
refFrags=as.numeric(MyMapFrags$PA_series.n$fragments))
# 675
fragPlot(as.data.frame(peak.list.pa[[588]]), limits=c(140, 725), 
refFrags=as.numeric(MyMapFrags$PA_series.n$fragments))
# or
fragPlot(as.data.frame(peak.list.pa[[657]]), limits=c(140, 725), 
refFrags=as.numeric(MyMapFrags$PA_series.n$fragments))
#######################################################################
# What about TAGs?
peak.list.tag <- peakList(xr[[10]])
TAGs <- c(551.5034, 565.5190, 579.5347, 593.5503, 607.5660, 621.5816, 
635.5973, 549.4878, 563.5033, 577.5190, 591.5346, 605.5503, 619.5659, 
633.5816, 547.4721, 561.4877, 575.5034, 589.5190, 603.5347, 617.5503, 
631.5660)
peak.frags.TAGs <- peakFragsPPM(peak.list.tag, tags=TAGs, ppmCut=10)
found.frags.TAGs <- rmNullObs(peak.frags.TAGs)
# Split the nested list into a single data frame
found.frags.TAGs <- unlist(found.frags.TAGs, recursive=FALSE)
all.frags.TAGs <- t(sapply(1:length(found.frags.TAGs), function(i) 
found.frags.TAGs[[i]]))
f.scan.tag <- paste(all.frags.TAGs[,1], all.frags.TAGs[,2], sep="_")





# Use this one




# Use this one




# Use this one
fragPlot(as.data.frame(peak.list.tag[[160]]), limits=c(500, 950), 
refFrags=TAGs, ppmThresh=15, mar=c(1,1,1,0))
# TAG 878
refFrags.tag_879 <- c(577.5190, 579.5347, 605.5503)
# pdf("~/Documents/Projects/Moody/Yasu/YM_FigureS2E_v2_raw.pdf", 
family="ArialMT", height=6.83, width=6.83)













# Use this one
fragPlot(as.data.frame(peak.list.tag[[94]]), limits=c(500, 950), 
refFrags=TAGs, ppmThresh=10, mar=c(1,1,1,0))





DAG.parents <- MycoMass[grepl("DAG", MycoMass$Abbreviation),4][36:56]
DAGdelOH <- DAG.parents-35.03711
DAGdelR <- t(sapply(1:length(DAG.parents), function(i) DAG.parents[i]-
MyMapFrags$PA_series.n$fragments[c(8:10, 13:18)]-18.033825553))
DAGs <- data.frame(Parent=DAG.parents, DAGdelOH=DAGdelOH, DAGdelR)
# fragments from DAGs
DAG.List <- lapply(1:length(DAGs[,1]), function(i) { 
peak.frags.DAG  <- peakFragsPPM(peak.list.dag, 
tags=as.numeric(DAGs[i,]), ppmCut=10)
found.frags.DAG <- rmNullObs(peak.frags.DAG)
# Split the nested list into a single data frame
found.frags.DAG <- unlist(found.frags.DAG, recursive=FALSE)




fDAG.list <- lapply(1:length(DAG.List), function(i) {
setList.DAG <- DAG.List[[i]][DAG.List[[i]][,9] <= 600 & DAG.List[[i]][,






# Use this one
fragPlot(as.data.frame(peak.list.dag[97]), limits=c(140, 650), 
refFrags=refFrags.dag612, ppmThresh=15, mar=c(1,1,1,0))
